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ABSTRACT 
Mitochondrial DNA (mtDNA) is a polyploid genome that is present in 
hundreds or thousands of copies per cell. Due to this polyploidy arising 
mutations cause heteroplasmy: the co-existence of two or more distinct 
mtDNA variants in the same cell. Because of these features mtDNA variants 
can segregate mitotically in the tissues of an individual, leading to time-
dependent changes in the percentage of the heteroplasmic mtDNA variants. 
These time-dependent changes are governed either by neutral genetic drift or 
selection. 
Most human pathogenic mtDNA mutations are heteroplasmic and 
functionally recessive, meaning that a certain percentage, or threshold, of the 
mutant mtDNA variant must be exceeded prior to onset of clinical 
symptoms. Somatic mtDNA segregation of inherited and de novo mutations 
affects whether the threshold is exceeded, and is an important factor for 
determining disease onset and clinical severity. Some pathogenic mtDNA 
mutations exhibit tissue-specific mtDNA segregation patterns. The 
mechanisms involved in tissue-specific mtDNA segregation are poorly 
understood. The aim of this thesis was to uncover genetic regulators of 
tissue-specific mtDNA segregation and study their properties to gain insight 
on the potential mechanisms involved in this complex process. 
We investigated tissue-specific mtDNA segregation in a heteroplasmic 
mouse model that segregates two non-pathogenic mtDNA variants. These 
mtDNA variants are transmitted neutrally through the female germ line, and 
display tissue-specific mtDNA segregation in three tissue types: the liver, 
kidney and hematopoietic tissues. In these tissues there is selection for one 
mtDNA variant over the other.   
We identified Gimap3 as a candidate gene for modifying mtDNA 
segregation in the hematopoietic tissues, and showed that transgenic 
overexpression of an alternative variant of this protein modulates mtDNA 
segregation in the hematopoietic compartment. Thus we successfully cloned 
the first mammalian gene to modulate the segregation of mtDNA. In a 
follow-up study we investigated the role of Gimap3 and the functionally 
related gene Gimap5 in mtDNA segregation in mice. We uncovered a novel 
subcellular localization to the endoplasmic reticulum for the Gimap3 protein 
and demonstrated complex gene expression regulation for this gene. 
Furthermore, we established Gimap5, which encodes a lysosomal protein, as 
another modifier of mtDNA segregation in hematopoietic tissues. Taken 
together these results demonstrated the involvement of other organelles in 
the segregation of mtDNA.  
To study tissue-specific mtDNA segregation from another aspect we 
investigated the potential role of mitochondrial fission in mtDNA 
segregation. Mitochondrial fission has been implicated in mtDNA 
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segregation in the unicellular model organism yeast. We utilized a dominant-
negative mouse model for Dnm1l, a master regulator of mitochondrial 
fission. This mutation inhibits fission and causes hyperfusion of the 
mitochondrial network. We demonstrated that expression of the dominant-
negative Dnm1l modulated the mtDNA segregation in the hematopoietic 
tissues of mice, but had no effect on mtDNA segregation in other tissues or 
during transmission. 
In conclusion, we were able establish three genetic modifiers for tissue-
specific mtDNA segregation. Our findings represent the first genes identified 
that can modulate tissue-specific mtDNA segregation in mammals. These 
findings can be utilized to guide future research aiming to uncover the 
molecular mechanisms of tissue-specific mtDNA segregation, which can 
ultimately elucidate the genetics of pathogenic human mtDNA mutations. 
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1 Introduction 
Mutations in the human mitochondrial DNA (mtDNA) are an important 
cause of genetic diseases, and since the first causative mutations were 
reported in 1988 [1, 2] over 300 mtDNA mutations have been reported in the 
human mitochondrial DNA database (MITOMAP). MtDNA diseases often 
have severe clinical phenotypes and multi-organ dysfunction, with tissues 
such as the central nervous system, heart, skeletal muscles and liver most 
commonly affected. Efforts to identify treatments for mtDNA diseases have 
been unsuccessful and at present there are no effective therapies for these 
patients [3]. During this thesis work, advances in assisted reproductive 
techniques and changes in the legislation in the United Kingdom have 
cleared the way towards preventing the transmission of mtDNA mutations to 
children of known carriers. However, these techniques will not help patients 
already suffering from mtDNA disease and have stimulated ethical debate in 
the scientific community as well as in society in general regarding the 
introduction of heritable genetic modifications in humans. 
The characteristics of mtDNA are different to the nuclear genome, and it 
does not follow the well-known rules of inheritance established by Gregor 
Mendel.  MtDNA is a maternally inherited multi-copy genome present in 
hundreds or thousands of copies per cell. These copies are not always 
identical, a state referred to as heteroplasmy. In heteroplasmic situations, 
mitochondrial DNA variants segregate somatically within an individual and 
this can lead to changes in the heteroplasmy levels. Most pathogenic mtDNA 
mutations are heteroplasmic, and whether a tissue is medically affected 
depends on heteroplasmy level of the mutant mtDNA [4]. MtDNA 
segregation is an important factor that influences in which tissues the 
mutation load exceeds this critical threshold, and can therefore affect the 
disease-onset and outcome. Molecular mechanisms and genes involved in 
this process have remained elusive, which hampers accurate prognosis and 
genetic counseling for patients with mtDNA mutations. Ultimately, better 
understanding of the mechanism of mtDNA segregation could provide 
potential therapeutic targets to reduce mtDNA mutation load. 
In this thesis we investigated the genetic basis of mtDNA segregation in 
mouse models. We successfully established three genes that modify mtDNA 
segregation in a tissue-specific manner. These genes represent the first and 
at the time of completion of this thesis the only genes identified to be 
involved in mtDNA segregation in mammals.  
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2 Review of the literature 
2.1 Basic mitochondrial biology 
Mitochondria are essential organelles of eukaryotic cells that are best known 
for their role in energy production. All eukaryotic organisms contain an 
organelle of mitochondrial origin. In mammals, mitochondria are present in 
all nucleated cells. 
2.1.1 Mitochondrial origin and structure 
The evolutionary ancestor of the mitochondrion was a free living α-
proteobacterium that was engulfed by a predecessor of a eukaryotic cell. This 
hypothesis, called the endosymbiotic theory, was advanced by Lynn Margulis 
in the 1970s and is nowadays widely accepted [5]. There is still debate on the 
type of cell that phagocytosed the α-proteobacterium: a eukaryotic cell 
(already containing a nucleus) or a prokaryotic archaebacterium.  After this 
initial endosymbiotic event, the α-proteobacterium evolved into a permanent 
structure of the host cell, nevertheless maintaining some of it ancestral 
features, such as the double membrane, its own genetic material and specific 
translation machinery (reviewed in [6]). 
Mitochondria consist of a double membrane, of which the inner 
membrane forms folds called cristae. The number and shape of the cristae is 
dynamic and correlates with the metabolic status of the mitochondria [7]. 
The double membrane lines two distinct compartments: the mitochondrial 
matrix is encompassed by the inner membrane, whereas the space between 
the inner and outer mitochondrial membranes is referred to as the 
intermembrane space (Figure 1). These compartments host a variety of 
specific mitochondrial functions, but are connected by protein complexes 
spanning both of the membranes (reviewed in [8]). 
Review of the literature 
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Figure 1 Mitochondrial ultrastructure in a transmission electron micrograph of a mouse 
embryonic fibroblast. Imaging by Paula Marttinen. 
2.1.2 Cellular functions 
Mitochondria are involved in a wide variety of important cellular functions, 
including citric acid cycle, fatty acid oxidation, heme and steroid 
biosynthesis, regulation of cellular redox balance, synthesis of iron-sulphur 
clusters, cellular calcium buffering and regulation of programmed cell death, 
apoptosis. The best-known and key function of mitochondria, however, is the 
aerobic production of energy for the cell in the form of ATP, an adenosine 
triphosphate molecule, by oxidative phosphorylation (OXPHOS). 
In mitochondria, derivatives from nutrient catabolism are further broken 
down by enzymatic reactions in the citric acid cycle, which produces the 
high-energy electron carriers NADH and FADH2 [9]. These carriers then 
supply the electrons to the process of oxidative phosphorylation. In oxidative 
phosphorylation electron flow down the mitochondrial respiratory chain 
(RC) is tightly coupled to the pumping of protons across the inner 
mitochondrial membrane to the intermembrane space, which creates an 
electrochemical gradient over the inner membrane. The electrochemical 
energy of this gradient drives the ATP production [10].  
The RC, also known as the electron transport chain, consists of four large 
multiprotein complexes (complexes I – IV) located in the mitochondrial 
inner membrane. The electrons from NADH and FADH2 enter the RC at 
complexes I and II, respectively, and via a stepwise reduction of the 
complexes are ultimately transferred to molecular oxygen producing water as 
the end product. Coupled to the electron transfer, protons are pumped from 
the matrix to the intermembrane space at complexes I, III and IV creating an 
electrochemical gradient across the inner membrane, referred to as 
mitochondrial membrane potential. The potential energy from this gradient 
is then converted to a chemical form by the ATP synthase, also located in the 
inner membrane, as proton re-entry to the matrix is coupled with the 
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phosphorylation of ADP to ATP. The four RC complexes and the ATP 
synthase together are often referred to as the OXPHOS complexes I-V. 
2.1.3 Mitochondrial dynamics 
In biology textbooks, mitochondria are often depicted as bean shaped 
independent organelles, but it has been long recognized that this view is too 
simplistic. Instead, mitochondria are dynamic organelles that undergo 
fission and fusion events, are transported via the cytoskeleton and form 
contacts the endoplasmic reticulum (ER).  
The distribution of mitochondria in the cell is determined by the balance 
of fusion and fission events, and the transport of organelles. These processes 
are integral for mitochondrial function, and disruptions in mitochondrial 
dynamics are associated with a variety of human diseases (reviewed in [11]). 
Mitochondrial morphology is responsive to physiological cues and a range of 
morphologies from fragmented to hyperfused can be observed under 
different conditions. Moreover, mitochondrial morphology is cell type 
specific: for example leukocytes contain round and more separate 
mitochondria, whereas mitochondria in cultured fibroblasts form connected 
networks (Figure 2). 
 
Figure 2 Confocal micrographs of mitochondrial morphology in different cell types. In the left 
panel a monkey COS-7 fibroblast cell transfected with a mitochondrially targeted 
GFP. In the right panel, a surface rendered 3D reconstruction of a primary mouse 
leukocyte with antibody staining against the mitochondrial protein CoxI. Note that 
the two panels are on different scales. Imaging by Paula Marttinen. 
2.1.3.1 Mitochondrial fission and fusion 
Mitochondrial fission is mediated by a nuclear-encoded large dynamin-
related GTPase Dnm1l (dynamin 1-like, often referred to as dynamin-related 
protein 1 or Drp1) that is conserved from yeast to mammals (Figure 3) [12-
14]. The yeast homolog of Dnm1-l is called Dnm1. Dnm1/Dnm1l contains 
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four distinct functional domains: the GTPase (G) domain, middle domain, 
variable B-insert region and a GTPase effector domain (GED). 
Dnm1/Dnm1l mediates mitochondrial fission by forming oligomer around 
mitochondrial tubule via self-assembly stimulated by GTP binding. The self-
oligomerization is initiated by dimer formation through middle domain 
interactions, which nucleates the formation of higher-order oligomer 
structures. The oligomer assembly stimulates GTP hydrolysis, which in turn 
drives a conformational change of the oligomer that constricts the 
mitochondrial tubule (reviewed in [15]). In yeast Dnm1 forms a spiral 
structure with a diameter of approximately 110 nm in the presence of a non-
hydrolysable GTP analog as measured by EM, and a recent study utilizing 
cryo EM reported similar results [16, 17]. Cryo EM also revealed that upon 
GTP hydrolysis, the Dnm1 spirals constrict to diameter of approximately 70 
nm [16]. The mammalian Dnm1l was originally reported to form ring-like 
structures with a diameter of 30 – 50 nm [12], but recent structural analysis 
discovered spiral like structures similar to the yeast Dnm1, suggesting similar 
mode of action between yeast and mammals [18]. 
Dnm1l is a cytosolic protein that relocalizes to mitochondria when 
activated to mediate fission. How the relocalization is mediated is 
incompletely understood, but involves mitochondrial adaptor proteins and 
potentially cues from the endoplasmic reticulum (detailed in section 2.1.3.3). 
In yeast Dnm1 interacts with the mitochondria through the mitochondrial 
outer membrane protein Fis1 and adaptor proteins Mdv1 and Caf4 [19-22]. 
Of these only Fis1 has a mammalian homolog, but Fis1 in mammalian cells is 
not essential for fission [23-26]. However there are three mammalian-
specific mitochondrial outer membrane adaptor proteins important for 
mediating contacts between Dnm1l and mitochondria: Mff, Mid49 and 
Mid51/Mief. These adaptors may be at least partially functionally redundant 
(Figure 3) [23, 25, 27, 28].  
The activity of Dnm1l is regulated by post-translational modifications. 
Many different modifications on Dnm1l have been reported in response to 
various physiological stimuli, such as progression though the cell cycle or 
nutrient starvation. These modifications can have either activating or 
inactivating effect on Dnm1l function (for a review on Dnm1l post-
translational modifications, see [29]).  
Mitochondrial fusion is also mediated by evolutionary conserved 
dynamin-related GTPases: optic atrophy 1 (Opa1, Mgm1 in yeast) [30, 31] 
and mitofusins 1 and 2 (Mfn 1 and 2, single homolog Fzo1 in yeast) [32-34] 
(Figure 3). Mitochondrial fusion occurs in two stages: the fusion of the outer 
membrane mediated by Mfn1 and 2 and the inner membrane mediated by 
Opa1. Usually the fusion the two membranes is coordinated, although outer 
membrane fusion can proceed without accompanying inner membrane 
fusion in cells lacking both mitofusins [35]. The exact mechanism for fusion 
is not as well established as it for mitochondrial fission, but fusion GTPases 
are required on both opposing membranes. A mechanism, where the 
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GTPases on the opposing membranes oligomerize and pull the membranes 
together has been proposed (for a review of the molecular mechanism of 
fusion, see [36]). 
 
Figure 3 Schematic representation of key proteins involved in mitochondrial fission (green) 
and fusion (purple/blue). 
Mutations in Opa1, Mfns and Dnm1l cause mitochondrial morphology 
defects. Genetic ablation or dominant negative mutations of Dnm1l 
consistently lead to hyperfusion of the mitochondrial network, sometimes 
accompanied with a perinuclear collapse of the whole network. Similarly, loss 
of Opa1, Mfn1 or Mfn2 function leads to fragmentation of the mitochondrial 
network. Opa1, Mfn1 and 2 and Dnm1l are all essential for life – lack of any of 
these factors in mice is lethal during embryogenesis embryogenesis [34, 37, 
38]. 
2.1.3.2 Mitochondrial transport 
Mitochondria move in the cell along the microtubules and microfilaments of 
the cytoskeleton [39, 40]. This process is integral for proper distribution of 
mitochondria throughout the cytoplasm, and chemical disruption of the 
cytoskeleton leads to aberrant clustering of mitochondria [41, 42]. In 
mammals, mitochondria move predominantly along microtubules with the 
help of ATP dependent motor proteins, dyneins for retrograde and kinesins 
for anterograde movement (reviewed in [43]). While microtubule based 
movement is considered to be the major long range transport mechanism, 
there is evidence for myosin motor-based short-range movement along the 
actin filaments [44].  
How mitochondria are recruited for movement is not well understood, but 
one mechanism involving the mitochondrial outer membrane protein Miro 
and cellular calcium concentration has been described in the neurons of the 
fruit fly, Drosophila melanogaster, and in mammals. In mammals there two 
homologs of Miro, RHOT1 and 2 [45]. Miro is an atypical Rho GTPase with 
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EF-hand calcium binding motives, which localizes to the outer mitochondrial 
membrane and is involved in kinesin mediated anterograde movement of 
mitochondria (Reviewed in [46]). Two models have been put forward to 
explain the mitochondrial movement mediated by Miro. One model proposes 
that Miro interacts directly with the kinesin motor to allow for mitochondrial 
movement. High cellular calcium concentrations disrupt this interaction 
through the EF-hands, causing the mitochondria to detach from the kinesin 
motor and therefore from the microtubule [47]. In the other model, 
mitochondrial movement is allowed by Miro interaction with the kinesin 
motor only through an adaptor protein. High calcium concentration 
promotes direct association between Miro and kinesin, which would 
dissociate the whole complex, including the motor, from the microtubule and 
halt movement [48]. One adaptor protein, Milton, has been described in D. 
melanogaster, but there is no mammalian homolog for this adaptor. 
Mitochondrial transport in mammals has been especially studied in 
neurons, due to the complex architecture of these cells and manifestation of 
defects in mitochondrial dynamics as human neurological diseases. Dynamic 
movement of mitochondria has, however, been shown to be important for 
other cell types as well. In T cells, mitochondria are dynamically relocated 
during chemotaxis and immunological signaling, and these functions are 
impaired if mitochondrial movement is inhibited [49, 50]. 
2.1.3.3 The role of the endoplasmic reticulum in mitochondrial 
dynamics 
The endoplasmic reticulum is a large membranous organelle, which has key 
functions in the synthesis of luminal, secretory and membrane proteins, 
cellular calcium storage, cellular secretory pathway and lipid biosynthesis. 
Mitochondria and the endoplasmic reticulum form close and stable 
interactions, which are functionally relevant: the contact sites between the 
mitochondria and ER host coordinated lipid biosynthesis and calcium 
exchange between the two organelles. Calcium transfer between the 
mitochondria and ER is important for providing sufficient local calcium 
concentrations for mitochondrial outer membrane proteins, as well as 
playing a role in the regulation programmed cell death. These functions for 
contact sites are reviewed in [51]. 
In yeast a complex tethering the ER and mitochondria, ERMES (ER-
mitochondria encounter structure), has been identified [52]. ERMES is 
composed of four core proteins, which were identified by screening for 
mutants that can be rescued by artificial tethering of mitochondria and ER. 
In mammals, no structure corresponding to ERMES has been described. 
Mfn2 has been proposed to function as a tether between the two organelles in 
mammalian cells [53], but contradictory data was also recently published 
[54]. Furthermore, a fraction of ER that is attached to mitochondria can be 
isolated biochemically and is often referred to as the mitochondria-
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associated membrane (MAM) [55, 56]. This fraction has been shown to be 
important for lipid biosynthesis [55], and displays the characteristics of a 
lipid raft, a specialized membrane domain [57]. 
In yeast, the ER-mitochondria contacts are important for mitochondrial 
dynamics. Deletion of core units of the ERMES complex leads to defects in 
mitochondrial morphology and distribution [58-60]. The yeast homolog of 
Miro is Gem1, which associates with the ERMES complex [61]. Furthermore, 
ER-mitochondrial contact sites were shown to mark sites of mitochondrial 
fission, and both the ERMES complex and Gem1 associate with these 
structures [62, 63]. Interestingly, it has also been established that dynamic 
distribution of mitochondria to the newly forming bud during yeast cell 
division is dependent on the prior localization of ER to the bud, but not vice 
versa (reviewed in [64]). 
Evidence from recent years shows that ER-mitochondrial contacts also 
play an important role in mitochondrial dynamics in animal cells. Similar as 
in yeast, the ER has been shown to wrap around the mitochondria in areas 
where the mitochondria are constricted [62]. Dnm1l and one of its receptors, 
Mff, consistently localize to these sites to mediate fission. The constriction at 
the ER-mitochondrial contact sites does not require Dnm1l, indicating that 
this constriction may be an initiating event in mitochondrial fission. The 
connections between these organelles appear to be very stable as they are 
maintained even during organelle movement along the cytoskeleton [65]. 
Further support for ER involvement in mitochondrial fission was 
provided by a set of experiments that linked the ER resident protein, inverted 
formin 2 (INF2) to Dnm1l mediated fission [66]. INF2 functions in actin 
polymerization and depolymerization, and the expression of a constitutively 
active mutant of this protein increased the frequency of fission. This effect 
was suppressed by a dominant-negative mutation in Dnm1l, demonstrating 
that INF2 functions upstream of Dnm1l. Similarly, the effect of INF2 on 
fission was dependent on actin polymerization, and a link between actin 
cytoskeleton integrity and Dnm1l mediated fission had previously been 
reported [67, 68]. Recently a role for myosin II, a member of the Myosin 
motor protein family capable of constricting actin filaments, in fission was 
discovered: myosin II colocalizes with the ER-mitochondrial constriction 
sites in an actin and INF2 dependent manner [69]. Inhibition of myosin 
motor proteins [67] has been shown to cause elongated mitochondrial 
morphology, but this effect was now attributed specifically to myosin II [69]. 
Based on these results, a theory for the initial steps of mitochondrial fission 
was proposed [70]: At ER-mitochondrial contacts sites INF2 promotes actin 
filament formation. Myosin II then localizes to the site, and drives the pre-
fission constriction at this site. Mff and Dnm1l are subsequently recruited to 
the constriction site, and Dnm1l oligomerization mediates the fission event. 
In this model, the role of ER in determining the sites for mitochondrial 
fission is crucial, as the instigating factor is the ER-resident INF2. 
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2.1.3.4 Mitochondrial quality control 
The turnover of mitochondrial components is an incompletely understood 
process. There is a proteolytic system operating in mitochondria, that 
degrades misfolded or aberrant proteins in mitochondria, and the 
proteasome system can act on the proteins in the outer mitochondrial 
membrane (reviewed in [71] and [72], respectively). Furthermore, a new 
pathway of mitochondria derived vesicles that deliver cargo for degradation 
to lysosomes and to peroxisomes was discovered recently: these vesicles 
exhibit cargo specificity and have been shown to contain proteins and lipids, 
but not DNA [73, 74]. The molecular basis for the cargo selectivity is not at 
present clear. 
During the last ten years a model for mitochondrial quality control that 
links mitochondrial turnover as whole organelle via macroautophagy, a 
cellular process for catabolizing intracellular structures by delivery to 
lysosomes, with mitochondrial dynamics has been developed (reviewed in 
[75]). This model proposes that damaged mitochondrial contents are 
removed by segregating them away from the mitochondrial network through 
fission, preventing their re-entry to the network by inhibiting fusion and 
degradation by a selective form of autophagy, termed mitophagy [76].  
The experimental basis for this model comes from a series of experiments 
in cultured mammalian cells and involves the mitochondrial protein Pink1 
and the E3 ubiquitin protein ligase Parkin. When cultured cells are treated 
with chemical uncouplers, the membrane potential dissipates and Pink1 
stabilizes on the mitochondrial outer membrane [77, 78]. The stabilized 
Pink1 then phosphorylates ubiquitin and Parkin, leading to activated Parkin 
on the mitochondrial outer membrane [79].  Activated Parkin subsequently 
flags the organelle for mitophagy, and ubiquitinates the Mfns, thus 
promoting their degradation and inhibiting the mitochondrion from fusing 
back to the mitochondrial network [80]. (For a detailed review on 
Pink1/Parkin mediated mechanisms for mitophagy in mammalian cells, see 
[81]). 
It is at present unclear, whether Pink1/Parkin mediated mitochondrial 
quality control occurs in vivo in animals. Metabolic labeling studies in mice 
and flies have uncovered turnover times for the OXPHOS complexes that 
differ by an order of magnitude, which seemingly argues against mitophagy 
as the predominant form of turnover for mitochondrial contents at steady 
state level as degradation of the whole organelle should lead to more 
synchronized protein kinetics [82-84]. Therefore, further research in animal 
models is required to assess if mitophagy is quantitatively an important form 
of mitochondrial quality control in animal tissues under mitochondrial stress 
situations. 
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2.2 Mitochondrial DNA and genetics 
2.2.1 Mitochondrial DNA 
Mitochondria contain their own genome, which is the only genetic material 
outside of the nucleus in animal cells. The genome size for animal mtDNA is 
small (typically 15-20 kilobases) and the gene content is highly conserved 
within the animal kingdom (reviewed in [85]). It is thought that the size of 
the animal mtDNA has shrunk during evolution as some of the mitochondrial 
genes have relocated to the nucleus through lateral gene transfer (reviewed 
in [86]). 
The human mtDNA, which is highly conserved with the mouse mtDNA, is 
a circular 16.6 kilobase molecule that is located in the mitochondrial matrix 
[87, 88]. The mtDNA does not contain introns and there is only one major 
non-coding area, the D-loop (the displacement loop), which contains the 
regulatory sequences for the mtDNA replication of origin as well as the 
promoters for transcription. MtDNA encodes for 37 genes: 13 polypeptides 
and the two ribosomal RNAs and 22 transfer RNAs required for their 
translation (Figure 4). The mitochondrial DNA is double-stranded, and the 
open reading frames of protein coding genes are distributed unevenly 
between the strands. 12 protein coding genes are located in the heavy strand 
as opposed to only one in the light strand. The two strands are labeled heavy 
and light based on their density difference CsCl gradients due to their 
differing guanidine content. The 13 polypeptides encoded by the mtDNA are 
essential subunits of the RC complexes I, III-IV and ATP synthase. 
There are over one thousand proteins found in mitochondria [89] and the 
vast majority are encoded by the nucleus, translated by cytosolic ribosomes 
and transported into mitochondria. This applies to RC complexes and ATP 
synthase as well: the majority of subunits are encoded by nuclear genes. 
Therefore, these complexes contain contributions from both the nuclear and 
mitochondrial genome. Furthermore, mitochondrial ribosomes are also 
dependent on both genomes, as the two ribosomal RNA components are 
encoded by mtDNA while all of the protein components encoded by the 
nucleus. This places these two mitochondrial processes under unique dual 
genetic control. 
The mtDNA is a polyploid genome, which is present in cells in numbers 
ranging from 102 to 105. Due to this polyploidy mutations give rise to 
heteroplasmy: the co-existence of more than one variant within the same cell. 
Heteroplasmy is of often reported as the percentage of one of the genomes. 
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Figure 4 Mitochondrial DNA and it’s gene products. The mammalian mitochondrial DNA 
encodes subunits of complexes I and III-V of the OXPHOS system, transfer RNAs 
and the ribosomal RNAs of the mitochondrial ribosome. 
2.2.1.1 Replication and repair of mitochondrial DNA 
Mitochondrial DNA is replicated by dedicated proteins encoded in the 
nucleus. The minimal replisome for mitochondrial replication has been 
reconstituted in vitro, and it contains the DNA polymerase gamma (PolG), 
Twinkle helicase and the single stranded DNA binding (mtSSB) protein [90]. 
Mitochondrial DNA replication is considered to be relaxed, which means that 
it is not strictly tied to the cell cycle in comparison to the nuclear genome 
[91]. Template selection appears to be random, and some mtDNA molecules 
may replicate more than once and some not at all during the cell cycle. The 
mechanism for mitochondrial DNA replication is controversial and three 
alternative models have been proposed (reviewed in [92]). These models may 
not be mutually exclusive.  
In the traditional model for mammalian mtDNA replication, the strand-
displacement or the strand-asynchronous model, replication of mtDNA 
heavy strand initiates in the D-loop region and displaces the light strand 
from the duplex. After proceeding approximately two thirds of the length of 
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the mtDNA molecule the replication of the light strand to the opposite 
direction is initiated. The model was originally based on the partially single-
stranded replication intermediates observed by electron microscopy [91, 93], 
but is also supported by data from atomic force microscopy and 2D gel 
electrophoresis [94]. 
This model was challenged after identification of replication 
intermediates by neutral two dimensional (2D) agarose gel electrophoresis 
that were considered inconsistent with the strand-displacement model, and 
led to the proposal two new models of mtDNA replication: the strand-
coupled model and RITOLS (ribonucleotide incorporation throughout the 
lagging strand) replication [95, 96]. In RITOLS replication it is proposed that 
RNA is incorporated into the lagging strand as the replication for the leading 
strand proceeds. The RNA is subsequently replaced by DNA by an unknown 
mechanism [97, 98].  In the strand-coupled model mtDNA replication is 
proposed to happen via a more traditional mechanism simultaneously on 
both strands with the generation of Okazaki fragments on the lagging strand 
[95, 99]. 
In addition to replication of new molecules, damaged mtDNA can be 
repaired in mitochondria. The repair mechanisms described for animal 
mtDNA are base excision repair and mismatch repair, of which base excision 
repair where the damaged base is recognized, excised and replaced is best 
characterized (reviewed in [100]). In contrast there appears to be little or no 
homologous recombination, a mechanism that repairs double-strand DNA 
breaks, in animal mitochondria. Recombinant mtDNA molecules were not 
detected in heteroplasmic mice under normal conditions by methods that do 
not rely on polymerase chain reaction (PCR) amplification [101, 102]. PCR 
based methods are prone for error caused by the polymerase jumping 
between two templates, and are therefore not appropriate for demonstrating 
the presence of recombinant molecules [102]. 
2.2.1.2 MtDNA copy number and mitochondrial biogenesis 
Mitochondrial DNA is a high-copy number genome, and mtDNA copy 
number is often used to estimate cellular mitochondrial content together 
with enzyme activity assays for mitochondrial enzymes such as citrate 
synthase and cytochrome c oxidase [103]. Due to the dynamic nature of the 
mitochondrial network (see section 2.1.3), analysis of mtDNA copy number 
and/or enzyme activity is often more relevant than determining number of 
organelles per cell. 
Mitochondrial DNA copy number in animal cells is highly variable, 
ranging from hundreds of copies to hundreds of thousands of copies per cell. 
For example mtDNA copy number in peripheral blood cells is 150 copies per 
cell [104], whereas the heart has much higher mtDNA copy number of 8000 
per diploid nuclear genome [105]. A striking example of mtDNA copy 
number variation is seen in the female germ line, where the copy number 
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changes from approximately 200 copies in primordial germ cells to 150 000 
copies in mature oocytes [106-108]. MtDNA copy number is tightly regulated 
within a cell and mechanisms that determine the level of mtDNA copies per 
cell are not well understood 
MtDNA copy number is determined by the balance of mtDNA replication 
and turnover, and the quantity and activity of factors involved in these two 
processes. How mitochondrial DNA is turned over is not known, but 
transgenic studies of proteins involved in mtDNA replication and 
maintenance showed that overexpression of the catalytic subunit of PolG had 
no effect on mtDNA copy number in cultured mammalian cells [109]. In 
contrast, overexpression of both Twinkle and Tfam increase mitochondrial 
copy number in mice [110, 111]. The mechanism for increasing the copy 
number is different between the two: Twinkle overexpression increased the 
number of newly synthesized mtDNA molecules, indicative of a mechanism 
involving increased replication initiation, whereas Tfam did not lead to 
similar changes [112]. Instead, Tfam is has role in mtDNA stability based on 
the mounting amount of evidence that the quantity of mtDNA and TFAM 
correlate [111, 113-115]. 
As mtDNA copy number mirrors the organelle amount in the cell the 
factors that affect mitochondrial biogenesis also play a role in mtDNA copy 
number control. One of the best described regulators of mitochondrial 
biogenesis, PGC-1α (peroxisome proliferator-activated receptor-γ 
coactivator-1α), is important in responding to physiological stimuli, such as 
endurance exercise [116, 117], cold exposure [118] and hypoxia [119]. It is a 
transcriptional coactivator that affects the transcription of nuclear 
respiratory factors 1 and 2 (NRF1 and NRF2) [120]. NRF1 and NRF2 
promote the transcription of several mitochondrially targeted factors to 
induce biogenesis. PGC-1α can in turn be activated by several cellular 
pathways, including AMPK (AMP-activated protein kinase) and Sirtuin 
mediated cellular pathways that are involved in cell energy status signaling 
(reviewed in [121]).  
In complex multicellular organisms like mammals, a big demand for 
mitochondrial biogenesis occurs during embryonic development and post-
natal growth. Surprisingly, PGC-1α is not required for this basal 
mitochondrial biogenesis, as knock-out mice for this factor are viable and 
fertile [122]. It is not known how the cell detects or establishes elementary 
mitochondrial content. Recently, a new hypothesis based on studies in 
cultured mammalian cells was put forward that proposes a role for 
translation on mitochondrial ribosomes in this signaling [123]. 
2.2.1.3 Nucleoids 
Historically, mtDNA was considered to be mostly naked in mammalian cells. 
However, evidence accumulated over the last decades shows that the 
mitochondrial DNA associates with proteins and forms discreet structures 
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called nucleoids (reviewed in [124]). The structure and behavior of the 
nucleoids form the basis for understanding mitochondrial genetics, and is a 
fundamental subject in mitochondrial biology. 
Nucleoids reside in the mitochondrial matrix and associate with the inner 
membrane [125], although the nature of this association and the identity of a 
potential membrane anchor are unknown to date. Nucleoids can divide and 
replication of mtDNA occurs at the nucleoids, but only a subset of nucleoids 
is replicated [125-127]. The mechanisms governing which nucleoids are 
involved in mtDNA replication are not known.  
The estimates of mtDNA copies per nucleoid vary slightly, but the 
reported values range within 1 – 10 copies per nucleoid in cultured 
mammalian cells [127-131]. Recent studies with super resolution microscopy  
across a variety of cultured human, mouse, primate and marsupial cells 
revealed that the average size of the nucleoid is 100 nm, and either spherical 
or ellipsoid in shape [128-130]. However, the size and composition of 
nucleoids has not been investigated in differentiated tissues in vivo. 
The proteins that associate with mtDNA are called nucleoid proteins. The 
most abundant and well established structural protein of the nucleoids is 
TFAM (mitochondrial transcription factor A), which colocalizes consistently 
with mtDNA by confocal and super resolution microscopy [125, 126, 129]. 
TFAM is a high motility group (HMG) protein that contains two HMG 
domains that intercalate mtDNA and linker region that interacts with the 
DNA backbone [132, 133]. TFAM is capable of coating and bending mtDNA 
by binding unspecific mtDNA sequences in a cooperative manner every 40 
nm [134, 135]. Asides from TFAM, a number of proteins has been identified 
by biochemical methods to associate with the mtDNA, but their structural 
role is not established (reviewed in [136]).  
Two models have been put forward regarding dynamics of the nucleoid 
structure: the faithful nucleoid model and the dynamic nucleoid model. The 
faithful nucleoid model postulates that each nucleoid replicates its specific 
genetic content, and that there is no mixing of genetic material between 
separate nucleoids [137]. In contrast, the dynamic nucleoid model allows for 
exchanging of mtDNA molecules between discreet nucleoids [138]. In 
cultured cells, the nucleoids are indeed dynamic structures that move within 
and are dispersed throughout the mitochondrial network [125, 127, 129]. If 
cells devoid of mtDNA, ρ0 cells, are fused with a karyoplast containing 
mtDNA nucleoids, the nucleoids are able to repopulate a mitochondrial 
network [126]. However, studies in yeast [139] and cultured human cybrid 
cells [140] provide evidence that nucleoids mainly do not interchange genetic 
material with each other, although functional complementation occurs. 
2.2.2 Transmission of mtDNA 
In mammals, mitochondrial DNA is strictly maternally inherited through the 
oocyte to all of her offspring [141]. Paternal mtDNA is degraded after 
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fertilization, although the mechanism in mammals is currently unknown. In 
Caenorhabditis elegans, a mechanism involving autophagy has been 
reported [142]. This strict regulation of maternal mtDNA inheritance can, 
however, be disrupted by inter-species crosses in mice, proposing the 
existence species specific factors that recognize the maternal and/or paternal 
mtDNA contributions [143]. In only one instance has paternal transmission 
in humans been reported [144], and thus paternal transmission appears to be 
extremely rare [145]. 
During embryonic development of mammals the quantity of mtDNA is 
tightly regulated. In mice, the mature oocyte contains over 150 000 copies of 
mtDNA, but the number is reduced as mitochondrial replication is halted 
until embryonic day 7.5 (reviewed in [146]). This leads to reduction of 
mtDNA copy number in the developing embryo at every cell division. MtDNA 
quantity in the oocyte is imperative for embryo viability. Experimental 
evidence from mice shows that an oocyte with abnormally low mtDNA copy 
number (4000 copies) can still be fertilized, but only embryos with an initial 
mtDNA copy number of at least 40 000 are capable of successful 
implantation to the uterine wall [106].  
The existence of a mitochondrial genetic bottleneck in the female germ 
line was proposed more than 20 years ago to explain the behavior of 
heteroplasmic mtDNA variants during maternal transmission in cows [147, 
148]. In these studies rapid shifts in heteroplasmy levels were reported 
between generations. Shifts in the level of heteroplasmy between generations 
and maternal relatives are also observed in pedigrees transmitting 
pathogenic human mtDNA mutations. The mitochondrial genetic bottleneck 
hypothesis was first experimentally investigated in a heteroplasmic mouse 
model [149]. This study experimentally demonstrated the existence of a 
mitochondrial bottleneck in the female germ line, and showed that the shifts 
in heteroplasmy level predominantly occur prior to the formation of primary 
oocytes. The shifts were modeled to be explained by random genetic drift in a 
population of approximately 200 mtDNAs. Analysis of the mtDNA 
bottleneck in human pedigrees transmitting pathogenic mtDNA mutations 
by using the same mathematical modeling yielded similar estimates of 
mtDNA copy number, indicating similar mechanism between mice and 
humans [149].  
While there is consensus of the mitochondrial genetic bottleneck, the 
precise timing and mechanistic basis remains under some debate. Studies 
utilizing various single cell based methodologies reported conflicting results 
on the lowest mtDNA copy number during oogenesis: the lowest copy 
number was measured in mouse primordial germ cells (PGCs) to be 
approximately 200 copies [107, 108] or an order of magnitude higher in the 
range of 103 [150, 151]. One study proposed that the physical reduction in the 
copy number in PGCs facilitates the genetic bottleneck [108]. Another study 
proposed a mechanism based on selective mtDNA template replication later 
in development during folliculogenesis, based on analysis on which stage of 
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oocyte development the variation in the heteroplasmy levels was determined 
[107].  
2.2.3 MtDNA segregation 
To ensure continued existence of functional mitochondria, mtDNA 
containing organelles must be transmitted to daughter cells at cell division. It 
is not known how transmission of mtDNA is mediated in mammalian cells, 
but it may be dependent on passive mechanims via distribution of organelles 
throughout the cytosol. There is evidence that the distribution of 
mitochondria is strictly regulated during the cell cycle. Dnm1l mediated 
mitochondrial fission is activated during mitosis to give rise to a fragmented 
network of mitochondria [152, 153], which could facilitate passive 
transmission. 
In the most fundamental form the term mtDNA segregation can refer to 
the transmission of mtDNA at cell division. However, it is often used to 
describe the temporal changes in the level of heteroplasmic mtDNA variants 
in cells and tissues of an individual. In this thesis, the term mtDNA 
segregation refers to the latter. In heteroplasmic situations mtDNA 
molecules can segregate mitotically because mtDNA replication is not strictly 
tied to the cell cycle as each template replicates independent of each other 
(see the previous section 2.2.2.2) and as described above, there is no known 
mechanism to ensure equal distribution of mtDNAs to daughter cells at cell 
division. This in contrast to the nuclear genome, for which strict regulatory 
mechanisms that ensure that each chromosome is replicated exactly once per 
cell cycle and one copy segregated to daughter cells at mitosis exist. Mitotic 
segregation of heteroplasmic mtDNA variants can lead to changes in the 
relative proportion of the heteroplasmic mtDNA variants (Figure 5). 
Heteroplasmic mtDNA variants can also segregate in post-mitotic tissues, as 
relaxed mtDNA replication is not dependent on mitosis and additional 
intracellular processes, such as mitochondrial turnover can affect the 
frequency of heteroplasmic mtDNA variants in tissues of an individual. 
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Figure 5 Schematic illustration of mtDNA segregation during mitosis. 
The segregation of heteroplasmic mtDNA variants can be modeled by 
using population genetics as the changes in the frequency of heteroplasmic 
mtDNA variants is analogous to changes in the allele frequencies within a 
population. There are two key concepts relevant for mtDNA segregation: 
genetic drift and selection. Genetic drift describes the changes in allele 
frequencies due to random sampling. The effect of drift is larger when the 
frequency of an allele is low, and in small populations. In the case of mtDNA 
segregation, the heteroplasmy level is equivalent to allele frequency. The 
question of the population size is somewhat more complicated, as it is at 
present unknown which is the precise entity that represents the segregating 
unit in tissues: the mtDNA, nucleoid or the organelle. Population size of the 
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segregating units is dependent on this knowledge. In contrast to the random 
nature of genetic drift, selection occurs when a certain allele affects the 
fitness, or in other words the survival and reproductive capacity of an 
organism. In mitochondrial terms, if a certain haplotype has a fitness 
advantage or disadvantage, this haplotype will either increase or diminish 
with time, respectively. 
In most cases segregation of heteroplasmic mtDNA variants is considered 
random and mathematical modeling has shown that it is dependent on 
mtDNA copy number and turnover rate [154]. Therefore changes in the 
relative heteroplasmy levels in most tissues are very slow, as mtDNA copy 
number is high. In contrast, when copy number is low changes in the 
heteroplasmy level can be detected, as is seen in the female germ line (see 
section 2.2.2). Similarly, selection against a heteroplasmic mtDNA variant 
can lead to detectable changes in the heteroplasmy level. Selective mtDNA 
segregation phenotypes have been described in patients with pathogenic 
mtDNA mutations and in heteroplasmic mouse models, and are detailed in 
the following sections 2.3 and 2.4, respectively. Such selective pressures 
could be exerted at any regulatory level that affects the segregation of the 
mitochondrial genome. Furthermore, if the heteroplasmic mtDNA variants 
affect the fitness of the cell differently, selection can happen on the level of 
the cells with different heteroplasmy levels generated by random drift. In 
such instance, selective mtDNA segregation would be detected at tissue level, 
even though the selective mechanism is not involved in the basic processes 
that determine mtDNA segregation. Potential regulatory processes for the 
segregation of heteroplasmic mtDNA variants are listed in Figure 6. 
 
Figure 6  Possible regulatory processes of mtDNA segregation. 
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2.3 Mitochondrial diseases and heteroplasmy in human 
health 
Mitochondrial defects underlie a wide variety of diseases, which are 
collectively classified as mitochondrial diseases. The exact prevalence of 
mitochondrial disease is not known but has been estimated to be 
approximately 1:5000 in England and 1:8000 Australia [155-157]. The 
prevalence of mitochondrial DNA mutations in the general population has 
been estimated to be as high as 1 in 200, making mtDNA mutations highly 
relevant for human health [158]. Furthermore, mtDNA mutations have been 
implicated in ageing. In recent years the prevalence of heteroplasmy has been 
shown to be much more common than previously thought in the general 
population, highlighting the importance of understanding the behavior of 
heteroplasmic mtDNA variants. 
As mitochondria depend on both the nuclear and mitochondrial genomes, 
gene defects in either genome can cause mitochondrial disease. While 
diseases caused by nuclear gene defects comprise an important group of 
mitochondrial diseases, the mutations in the mitochondrial DNA are most 
relevant for this thesis. Therefore, mitochondrial diseases caused by nuclear 
gene defects are not discussed with the exception of diseases caused by genes 
involved in mitochondrial morphology. 
2.3.1 Defects in mitochondrial morphology genes  
Mitochondria are dynamic organelles that undergo fusion and fission events 
(summarized in section 2.1.3.1), and mutations in the genes encoding for 
factors involved in mitochondrial fusion (OPA1, MFN2) and fission (DNM1L) 
impair mitochondrial function and cause human diseases. OPA1 mutations 
are predominantly dominant and cause optic atrophy [159], sometimes 
associated with other neurological phenotypes (reviewed in [160]). A recent 
report described the first recessive OPA1 disease mutation that results in 
infantile onset encephalopathy and cardiomyopathy [161]. Dominant and 
recessive MFN2 mutations manifest as the neurological syndrome Charcot-
Marie-Tooth disease (reviewed in [162]), whereas no causative disease 
mutations have been reported for MFN1. To date, two patients with a 
dominant DNM1L mutations have been reported leading to lethal 
encephalopathy and metabolic crisis in neonatal period [163] or 
developmental delay and epilepsy within the first year of life [164]. A recent 
report attributes neurological symptoms following an infection in three 
children to defects in the activation of DNM1L through post-translational 
modifications [165]. Moreover, a homozygous truncation of MFF has also 
been identified by whole-exome sequencing in two children of the same 
family with developmental delay and other neurological symptoms [166].  
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2.3.2 Pathogenic human mtDNA mutations 
Mutations in the mtDNA can affect any of the OXPHOS coding subunits or 
the tRNA and rRNA genes involved in their translation. The mutations can 
be rearrangements or point mutations, and since the first discoveries in 1988 
of a point mutation in the mitochondrial ND4 gene as the cause of Leber’s 
hereditary optic atrophy [1] and mitochondrial DNA deletions as the cause 
for myopathy [2], over 300 mtDNA mutations have reported in MITOMAP: a 
human mitochondrial DNA database (www.mitomap.org), to date.  
Most mtDNA mutations are heteroplasmic, and a certain percentage of 
mutant to wild type mtDNA must be exceeded before the mutation manifests 
as a clinical disease. This percentage, or threshold, is mutation specific. 
Usually the threshold is approximately 60% for mtDNA deletions and 85% 
for point mutations [167-169], but much lower threshold values have also 
been reported [170]. The segregation of mutant mtDNA molecules across 
tissues during embryogenesis or post-natal life is therefore one of the factors 
that can affect age-of-onset and the clinical manifestation of the disease. 
All mutations in mtDNA can impair the function of the oxidative 
phosphorylation system either via directly affecting the subunits, or through 
affecting their synthesis. It is therefore perhaps surprising that the disease 
phenotypes associated with mtDNA mutations are highly variable: the range 
spans lethal multisystem disorders and defects in isolated organs, such as the 
optic nerve. They can have any age of onset, and affect almost any organ with 
the nervous system, skeletal muscles, heart and liver being the most 
commonly affected tissues. Moreover, the genotype-phenotype correlation in 
diseases due to mtDNA mutations is complex: some syndromes, such as 
MELAS (mitochondrial encephalopathy, lactic acidosis and stroke-like 
episodes) can be caused by mutations in different genes, and mutations in 
the same gene can cause different syndromes in different patients. For 
example, the A3243G mutation in the anti-codon region of the tRNALeu gene 
is commonly associated with MELAS [171, 172], but also implicated in 
chronic progressive opthalmoplegia, maternally inherited deafness and 
diabetes and cardiomyopathy in different pedigrees [173-175] (the clinical 
phenotypes of mtDNA mutations are reviewed in [176]). At the moment there 
are no curative treatments for diseases caused by mtDNA mutations. 
2.3.2.1 Genetics of pathogenic mtDNA mutations 
Many pathogenic mtDNA mutations exhibit skewed tissue distribution [167, 
177-183]. In fact, one of the first studies showing mtDNA mutations as the 
causative molecular defect in human disease reported accumulation of 
mtDNA deletions in muscle, although these deletions could not be detected 
from the blood [2]. Similar findings were soon reported in other studies of 
mtDNA deletions [184, 185] as well as in post-mitotic tissues of aging 
individuals [186, 187], and prompted the hypothesis that some selective 
advantage of the mutant mtDNA operating in post-mitotic tissues accounts 
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for the expansion of deleted mtDNA molecules. The same deletion can also 
underlie distinct phenotypes in the same individual, depending on the tissue 
distribution. For example, Pearson marrow pancreas syndrome is a severe 
and often fatal childhood early-onset disease characterized by sideroblastic 
anemia [188]. However, some patients spontaneously recover only to later 
develop symptoms of Kearns-Sayre syndrome, a severe disorder that mainly 
affect post-mitotic tissues [184]. This is thought to be due to selection against 
the deleted mtDNA molecule in the hematopoietic stem cells or early 
progenitors, as the deleted molecule is often still detectable in the long-lived 
circulating white blood cells after the recovery from anemia. 
MtDNA point mutations can segregate in a tissue specific manner, and 
the segregation pattern can be dependent on the mutation and/or the patient 
pedigree. In patients manifesting with a neuromuscular diseases the 
proportion of the mutant mtDNA is commonly higher in post-mitotic tissues 
[158, 179, 189].  In some patients the mutation has been reported to 
segregate to the muscle while being undetectable in other tissues [180, 190]. 
Within the muscle, the mutant mtDNA variant may segregate in cell specific 
way: ragged-red muscle fibers are a common muscle phenotype for mtDNA 
mutations characterized by abnormal accumulation of mitochondria, 
respiratory chain dysfunction and higher heteroplasmy levels than 
neighboring muscle fibers. It is thought that the focal segregation of the 
A3243G mutation to ragged red fibers in the muscle of chronic progressive 
external opthalmoplegia (cPEO) patients as opposed to the more uniform 
distribution of the mutation in the muscle of MELAS patients underlies the 
difference in these two distinct syndromes [182]. 
As point mutations can be heritable, their tissue distribution can be 
affected by mtDNA segregation during embryogenesis or post-natal life. The 
data obtained from a single time point and in a small number of tissues in 
general does not allow for elucidation of the timing when the tissue 
distribution of a particular mutant mtDNA is determined, but limited data on 
few mutations implies random mtDNA segregation for point mutations 
during intrauterine development [191-193].  
Based on the observations made in the patients with mtDNA mutations it 
may intuitively seem that mtDNA mutations accumulate in post-mitotic 
tissues via some selective mechanism. Such accumulation can however be 
explained also by random genetic drift in combination with ascertainment 
bias without invoking any selective mechanisms. Data regarding pathogenic 
mtDNA mutations is only derived from patients (and their families) in whose 
tissues the mtDNA mutant load reaches pathogenic level and they are 
clinically investigated, whereas carriers who never manifest the disease and 
have no family history of mitochondrial disease will never be investigated for 
mtDNA mutations. This generates an ascertainment bias in the data. 
Moreover mathematical modeling has shown that random intracellular 
genetic drift and clonal expansion of cells can explain the apparent post-
mitotic accumulation of pathogenic and age-related mtDNA mutations, 
 33 
without invoking a selection mechanism [154, 194]. The accumulation of 
mtDNA mutations in ragged red fibers may also be a result of random 
intracellular drift. In some cells the mutation load will be high due to genetic 
drift. High mutation load causes mitochondrial dysfunction and activates a 
general mitochondrial biogenesis program specifically in these cells and 
leads to the increase of all mtDNA molecules (both wild type and mutant 
mtDNA) in the cell. As these cells have proportionally higher mtDNA 
mutation load than the tissue on average mitochondrial proliferation will in 
time increase the overall  mutation load measured from bulk tissue, although 
the proportion of wild type and mutant mtDNA per cell is unchanged [154, 
177, 181].  
To establish selective mtDNA segregation instead of random intracellular 
drift requires showing consistent time-dependent changes in the frequency of 
the mutant mtDNA variant in large study cohorts. Most mtDNA mutations 
are rare and single measurements from a small number of patients are not 
sufficient to establish the mode of mtDNA segregation. The notable 
exceptions to this are the two most common pathogenic mtDNA tRNA 
mutations, A3243G and A8334G (commonly associated with myoclonic 
epilepsy with ragged red fibers, MERRF). For the A3243G mutation tissue-
specific selective mtDNA segregation has been demonstrated:  the 
heteroplasmy level of the A3243G mutation consistently and reproducibly 
decreases in the blood of patients from different pedigrees with age [195-
199]. Mathematical modeling suggested a mechanism based on selection 
against the pathogenic mtDNA mutant in the hematopoietic stem cells [199], 
but no experimental evidence corroborating this hypothesis has been 
reported. No selective mtDNA segregation phenotypes have been observed 
for the A8334G mutation, demonstrating that mechanisms affecting mtDNA 
segregation can be mutation specific as well as tissue-specific. 
As mtDNA point mutations can be transmitted through the female germ 
line, the segregation of the mutated mtDNA during oogenesis is an important 
factor determining the heteroplasmy level, and thus potential disease, in the 
resulting offspring. In pedigrees transmitting pathogenic mtDNA mutations, 
there is typically heterogeneity in the heteroplasmy levels between maternal 
relatives and generations [189, 198, 200]. Such shifts and heterogeneity are 
facilitated by the mitochondrial DNA bottleneck during oogenesis. Human 
pedigrees tend to be too small to distinguish between random and selective 
mechanisms, but based on one relatively large human data set of 82 primary 
oocytes from a carrier of the A3243G mutation, random genetic drift 
accounted for the variability in oocyte heteroplasmy levels [201, 202]. 
However, different mtDNA mutations may behave differently during 
transmission. Studies on a very limited number of oocytes and early embryos 
from carriers of another point mutation (T8993G) reported rapid segregation 
towards either very low or high heteroplasmy level [203-205].  
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2.3.3 Heteroplasmy in the general population 
Recent studies have uncovered that mtDNA heteroplasmy is common, if not 
universal, also in the general population. These studies utilizing next-
generation sequencing techniques consistently reported the presence of 
heteroplasmic mtDNA variants in all [206-208] or a significant proportion of 
individuals studied [209]. The initial reports were based on analyses on fairly 
low number of individuals, but the near universal presence of heteroplasmies 
was corroborated by a study utilizing samples from the 1000 genomes 
project, which detected heteroplasmy in 90% samples [210]. In most cases a 
single tissue was investigated, but a study investigating heteroplasmy across 
ten tissues in over a hundred individuals found that 35% of the 
heteroplasmies are present in a single tissue, whereas 65% are present in two 
more tissues [211]. The heteroplasmies reported in these studies represented 
both pathogenic and neutral polymorphisms, and were present from very low 
to high levels. Maternal transmission of heteroplasmy was also reported, but 
these studies relied on data on two families or pedigrees with gene defects in 
nuclear encoded mtDNA maintenance defects [206, 207]. In some studies, 
selective mtDNA segregation was speculated based on either recurrent 
presence of the same heteroplasmic mtDNA variants in the same tissues of 
unrelated individuals or excess of heteroplasmic variants with non-
synonymous changes detected in liver by comparison to other tissues [208, 
211]. Further research will show what implications this widespread existence 
of heteroplasmy has on human health. 
The accumulation mtDNA mutations in somatic tissues has been 
proposed to contribute to ageing (for a review on mitochondrial theory of 
ageing, see [212]). Analysis of aged individuals provides support for the 
mitochondrial theory of ageing: mitochondrial DNA deletions do accumulate 
with age, as does respiratory chain deficiency, but predominantly in the post-
mitotic tissues [186, 187, 213]. The data on mtDNA point mutations is 
however more controversial with some studies finding no evidence for 
accumulation of point mutations in normal ageing [207, 214] while others do 
[211, 215]. The role of mtDNA mutations in ageing has been experimentally 
studied in the Mutator mouse model where random mtDNA mutations are 
inserted at a high rate due to a proofreading defect in PolG. These mice 
exhibit a progeroid phenotype, further supporting for a role for mtDNA 
mutations in aging [216, 217]. Work with this mouse model revealed that 
mtDNA mutations cause somatic stem cell dysregulation that promotes cell 
proliferation over stemness that contributes to the premature ageing 
phenotype [218]. The somatic stem cell defects in the Mutator mice precede 
any detectable respiratory chain dysfunction in these mice, suggesting that 
more subtle changes in mitochondrial metabolism underlie the stem cell 
defect (for a review see [219]). 
MtDNA mutations have also been reported in cancer cells. Mitochondrial 
mutations that segregated rapidly to homoplasmy in colorectal tumors while 
being absent from the neighboring healthy tissue were first reported in 1998 
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[220]. These findings have been reproduced in both different types of solid 
tumors and leukemias [221-223]. Based on mathematic modeling the rapid 
segregation of mtDNA mutations in cancer cells can be explained random 
genetic drift and clonal expansion rather than positive selection for mtDNA 
mutations in cancer [224]. Therefore it is not at present clear whether these 
mutations contribute to, or are a result of, cancer progression.  
2.4 Experimental research on tissue-specific mtDNA 
segregation 
The segregation of heteroplasmic mtDNA variants in tissues can affect the 
age of onset and clinical outcome of mtDNA diseases, and lack of knowledge 
about the basic mechanisms of this process impedes accurate disease 
prognosis and genetic counseling. Ultimately, affecting the process of mtDNA 
segregation in a way that the mutated mtDNA variant would be selected 
against could represent a potential target for therapy for these patients, for 
whom there is no curative treatment available at the present time.  
Early experimental research for heteroplasmic mtDNA mutations was 
conducted in primary cells derived from patients and in cybrid (cytoplasmic 
hybrid) cell line. Cybrid cells are generated by fusing an anucleated cell 
containing the mutant mtDNA with a recipient cell, creating a hybrid cell line 
harboring the desired mtDNA mutation. Cybrids cell lines had been 
successfully used to demonstrate that mtDNA mutations underlie the 
biochemical OXPHOS defects in the patients independent of the nuclear 
background, and in determining the mutation-specific thresholds for 
biochemical defects (reviewed in [225]). Regrettably, this model failed to 
provide robust and reproducible results in the study of mtDNA segregation, 
as different groups reported variable and opposing results for the segregation 
behavior of the same mtDNA variant, potentially owing to the unstable 
aneuploid nuclear genetic background of the cybrid cells [226-228]. 
Furthermore the recipient cells used in the generation these cybrid cells were 
osteosarcoma or other cancer cell lines, and cannot therefore accurately 
model the tissue and/or cell type specific mtDNA segregation patterns seen 
in patients.   
The generation of a heteroplasmic mouse model segregating two non-
pathogenic mtDNA genomes twenty years ago facilitated the research of 
study mtDNA segregation in a more physiological context [149]. These 
mtDNA variants were derived from two old inbred strains, Balb/c and NZB, 
and differ at 90 nucleotide positions at the sequence level [102]. This model 
was originally created to study transmission of heteroplasmy but has proved 
useful for studying mtDNA segregation in somatic tissues as well. This model 
is referred to as the BALB/NZB model in this thesis. Other heteroplasmic 
mouse models have also been generated [229-232]. 
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2.4.1 Transmission of mtDNA variants and purifying selection 
Due to the uniparental inheritance mode, the mammalian mtDNA is 
fundamentally an asexually reproducing genome without homologous 
recombination. In principle, this should render the mtDNA vulnerable to 
Müller’s ratchet: the accumulation of deleterious mutations as they cannot be 
removed by recombination, and the mitochondrial genome does indeed 
accumulate mutations faster than the nuclear genome ([233], reviewed in 
[146]). The mitochondrial genetic bottleneck is thought to counteract this 
accumulation of mtDNA mutations in subsequent generations by exposing 
deleterious mtDNA mutations to purifying selection. 
The transmission of neutral mtDNA variants has been studied in the 
BALB/NZB model and there is no evidence for selection during transmission. 
Instead the transmission of the neutral mtDNA variants is consistent with 
random genetic drift with a small population of segregating units in the 
mitochondrial genetic bottleneck. To better model the segregation of 
heteroplasmic variants in the female germ line, a model of neutral genetic 
drift based on a modified Kimura distribution was developed [202]. The 
predictions of the modified Kimura distribution were shown to model the 
distribution of heteroplasmy in the offspring of heteroplasmic females of the 
BALB/NZB heteroplasmic mice and in oocytes derived from an A3243G 
mutation carrier. 
There is, however, experimental evidence for a purifying selection process 
against highly deleterious mtDNA mutations in protein coding genes from 
mouse models. In the offspring of female mice carrying a defective PolG 
(Mutator mouse model) that introduces random mtDNA mutations at a high 
rate, a strong bias against non-synonymous mutations in the protein coding 
genes was detected [231]. Furthermore, in a mouse model heteroplasmic for 
a deletion in the protein coding Nd6 gene, the mutation was selectively 
eliminated during oogenesis in a few generations [232]. In contrast no bias in 
transmission of mutations in the tRNA genes in the Mutator mice was 
reported [231], and no purifying selection against a mutant tRNA gene for 
methionine was observed in the female germ line. However for the 
heteroplasmic tRNA methionine the authors reported selection against very 
high mutation load in the embryos [230]. 
Based on these findings, there are processes in the female germ line that 
mediate purifying selection against certain mtDNA variants, but other 
variants escape this selection. In the light of current data, more severe 
mutations such as deletions and point mutations affecting the protein coding 
genes are selected against, whereas tRNA mutations and polymorphic 
variants appear to be inherited neutrally.  
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2.4.2 MtDNA segregation in somatic tissues of the BALB/NZB 
heteroplasmic mice 
In the BALB/NZB heteroplasmic mouse model the heteroplasmy levels are 
similar across tissues at birth, consistent with random mtDNA segregation 
during embryogenesis similarly to what has been reported for some 
pathogenic mtDNA mutations [191-193]. Post-natally, however, there is 
mtDNA selection in three tissue types: the liver, kidney and hematopoietic 
tissues. Surprisingly, the selection occurs in opposite directions in the 
tissues. The NZB genome is selected for and increases with time in the liver 
and kidney, whereas it is selected against in the hematopoietic tissues. The 
mechanism governing the segregation in liver differs from that in the 
hematopoietic tissues, because the dynamics of mtDNA segregation are 
different. In liver, the rate of segregation is constant and independent of the 
initial heteroplasmy level, leading to fixation of the NZB genome [234], 
whereas in the spleen segregation is best modeled as an exponential decay 
proportional to the initial heteroplasmy level [235]. Tissue-specific mtDNA 
selection has also been observed in other heteroplasmic mouse models, and it 
appears to be a common phenotype in heteroplasmic mice [229, 236-238]. 
As all of the polypeptide genes encoded by the mtDNA are subunits of the 
OXPHOS complexes differences in the capacity for ATP production could 
mediate selective mtDNA segregation phenotypes. Similarly, differences in 
replication rates between the heteroplasmic variants could lead to selection 
of one mtDNA variant over the other. However, there is no difference in 
these parameters between the two genomes in the BALB/NZB genomes [234, 
239]. Similarly in patients the MELAS mutation is selected against in the 
blood at levels well below the biochemical threshold for dysfunction for this 
mutation. Furthermore there is no selection against other pathogenic mtDNA 
variants in patient tissues where the threshold for biochemical defect is 
exceeded. Based on these data selection mechanisms that are not dependent 
on OXPHOS exist. 
2.4.2.1 Genetic modifiers of selective mtDNA segregation 
An advantage of mouse models is the ability to use forward genetics 
approaches to identify genes and pathways involved in phenotypes under 
investigation. The selection phenotype seen in the BALB/NZB model is 
common to all M. m. domesticus strains as shown by backcrossing with six 
different laboratory strains, precluding genetic mapping in these 
backgrounds. However, an intercross to another mouse subspecies M. m. 
castaneus (referred to as Cast/Ei hereafter) uncovered quantitative effects on 
the selective mtDNA segregation phenotypes in the liver, kidney and spleen 
in the F2 offspring, providing the first experimental evidence that nuclear 
genes can affect mtDNA selection [240]. The evolutionary lines of the two 
mouse subspecies diverged approximately one million years ago and thus 
there is more genetic variability than between different M. m. domesticus 
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strains. A genome wide linkage scan was performed on the F2 data and 
independent quantitative trait loci (QTL) were identified for each tissue. The 
QTLs were named segregation of mitochondrial DNA 1–3 (Smdq1–3) for 
liver, kidney and spleen respectively. Further backcrossing to the Cast/Ei 
background revealed that the mtDNA selection phenotype in the 
hematopoietic tissues can be completely lost on this background, confirming 
the presence of limited number of nuclear genes that regulate the mtDNA 
phenotype [235]. 
2.4.2.2 MtDNA selection in hematopoietic tissues 
In the BALB/NZB model, the selection against the NZB variants is common 
to both lymphoid and myeloid lineages [235]. The decrease in the relative 
amount of the NZB genome is proportional to the initial heteroplasmy level 
of the animal and can be modeled as an exponential decay function. This 
decrease is approximately 50% during the first 100 days of post-natal life, 
and eventually reaches an asymptote so that the NZB genome is never 
completely lost [235].  
The immune system defends the body from pathogens and in mammals 
the immune system is based on general pattern recognition by the innate 
immune system and specific pathogen recognition by the adaptive immune 
system. As mitochondria have prokaryotic origin and characteristics (see 
section 2.1.1), they could be recognized by the immune system as pathogens 
and a selection mechanism based on recognition of specific mtDNA variants 
by the innate or adaptive immune system and a subsequent immune reaction 
against them could be envisioned. While such a mechanism could explain 
mtDNA selection in any tissue type, this question has mostly investigated in 
the hematopoietic compartment. 
The adaptive immune system relies on the recognition of specific antigens 
from pathogens by T cells, and the formation of memory cells after first 
encounter (priming) for quick immune responses upon re-encounter of the 
same pathogen. Peptides derived from proteins encoded by the mtDNA have 
a role in priming the T cells against intracellular pathogens through 
presentation of mitochondrial peptides as self-antigens for T cells [241]. One 
of the nucleotide differences between BALB and NZB genomes is in the Nd1 
gene, which has been shown to function as a self-antigen [242]. Moreover, 
the gene required for the presentation of mitochondrial peptides is 
functionally null in Cast/Ei mice, where the selection against the NZB 
mtDNA in the hematopoietic tissues is lost [243], prompting the hypothesis 
that an adaptive immune system reaction against the NZB genome would 
underlie the mtDNA selection in the hematopoietic tissues of the BALB/NZB 
mice. This hypothesis was tested with transgenic mouse models incapable of 
presenting mitochondrial peptides (Tap1 and β-microglobulin knock-out 
mice) or incapable of mounting T-cell mediated immune responses (Rag1 
knock-out mouse) [235]. None of these genetic modifications affected the 
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selection against the NZB genome in hematopoietic tissues, showing that the 
selection is not dependent on adaptive immune responses or mitochondrial 
self-antigen presentation. Furthermore the Tap1 and β-microglobulin knock-
out had no effect on the mtDNA selection in the liver, demonstrating that 
mitochondrial self-antigen presentation does not underlie mtDNA selection 
in this tissue either. 
The role of the innate immune system has not been investigated in the 
BALB/NZB model, but one interesting study reported a role for the innate 
system in recognition of specific mtDNA variants [244]. Xenografts 
harboring either the same mtDNA as the host (syngenic) or distinct mtDNA 
(allogenic) were transplanted into mice, and specific rejection of the allogenic 
grafts was reported. This specificity was lost when the recipient mouse was of 
a transgenic strain with defective innate immune system (Myd99 knock-out 
strain), but not when the recipient mouse had a defect in adaptive immune 
system (Tap1 and β-microglobulin knock-out mice). Moreover, the ability of 
the innate immune system to recognize and select against the allogenic 
mtDNA was at least partially assigned for a specific cell type, the Natural 
Killer (NK) cells: specific reduction of NK cell quantity with an injection of an 
anti-NK cell antibody was sufficient to allow some tumor growth after 
transplantation, albeit slower than with syngenic transplant. The role of this 
interesting mechanism in tissues under normal physiological conditions is at 
present unknown, and requires further investigation. 
2.5 Gimaps (GTPases of the immunity associated 
protein) 
The Gimap gene cluster is a family of GTPases that was revealed to be 
important for tissue-specific mtDNA segregation by the work presented in 
this thesis. Therefore it is appropriate to discuss them here. 
The Gimap gene cluster is specific to vertebrates with an orthologous 
gene in Arabidopsis thaliana in which the prototype gene AIG1 for the family 
was identified. The common domain between A. thaliana AIG1 gene and the 
vertebrate Gimap family is the AIG domain, which contains the P-loop 
GTPase domain and a conserved box of unknown function (CB) [245-247]. 
Some of the Gimap proteins are soluble and reside in the cytosol, while 
others are membrane proteins with a carboxy-terminal transmembrane 
domain localizing to various subcellular compartments (Table 1). The Gimap 
genes reside in a cluster that in mice consists of eight functional genes on 
chromosome 6 and in humans seven functional genes on chromosome 7 
[245, 248, 249]. GIMAP2 is specific to humans, whereas Gimap9 is found 
only in mice [250]. Expression of the Gimap family is enriched in immune 
tissues [245, 246, 248, 249, 251-258]. 
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Table 1  Reported subcellular localizations of the Gimap family proteins in mice and 
humans. *Gimap7 does not contain a transmembrane domain, and may localize to lipid droplets 
via interaction with Gimap2 or other factors. NA stands for data not available. 
Protein 
Subcellular localization 
Reference 
Human Mouse 
Gimap1 
Endoplasmic 
reticulum 
Golgi [249, 259] 
Gimap2 Lipid droplets NA [260] 
Gimap3 NA Mitochondria [256] 
Gimap4 Cytosol Cytosol [261, 262] 
Gimap5 Lysosome Lysosome [259] 
Gimap6 Cytosol NA [261] 
Gimap7* 
Diffuse, 
lipid droplets 
NA [261] 
Gimap8 Cytosol 
Endoplasmic reticulum 
Mitochondrion 
Golgi 
[250, 261] 
Gimap9 NA NA  
 
The mammalian prototype gene of the family, Gimap1, was originally 
reported as a response gene to malaria infection [258], however, these results 
were not reproducible [263]. In the light of current data the Gimap proteins 
appear to be involved in leukocyte development and cell survival regulation, 
potentially through interactions with various Bcl-2 family regulators of cell 
survival[246, 248, 252, 262, 264-269]. However, the specific role of Gimaps 
in these functions is not known. In humans, the GIMAP locus associates with 
autoimmune disorders [270, 271], but causative disease mutations have not 
been reported.  
Structural analysis of the Gimap proteins revealed that these GTPases are 
most related to the dynamin family of membrane remodeling proteins and 
the septin family of intracellular scaffold proteins [260]. Analysis of the 
membrane-bound GIMAP2 showed that this protein has low inherent GTP 
hydrolysis activity and upon GTP binding, forms stable oligomers instead of 
GTP hydrolysis. Based on these findings and the homology to septins, it was 
proposed that the membrane-bound Gimaps could function as scaffolds that 
facilitate the binding of other factors. In contrast, the soluble GIMAP7 was 
able to readily hydrolyze GTP upon binding, and stimulate GTP hydrolysis 
and disassembly of GIMAP2 oligomers through hetero-oligomerization, thus 
providing a potential regulatory mechanism for Gimaps [261].  
Gimap3 and Gimap5 are two membrane-bound paralogs. 84% of their 
amino acid sequence is identical, with major variation seen only in the 
carboxy-terminal transmembrane domain and in the amino-terminus 
(Figure 7). GIMAP3 is annotated as a pseudogene in humans but as a 
functional gene in mice, whereas Gimap5 is a functional gene in both species. 
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Gimap3 had a reported subcellular localization to the outer mitochondrial 
membrane [256]. Gimap5 was originally reported to localize to various 
cellular membranes [248, 272], but more recent data utilizing species-
specific antibodies demonstrated a lysosomal localization for human, mouse 
and rat Gimap5 [259]. Both Gimap3 and 5 have been reported to interact 
with various Bcl-2 family factors, and to be important for lymphocyte 
development in fetal thymocyte cultures.  
 
Figure 7 Comparison of the protein domains between Gimap3 and Gimap5. Areas of major 
variation are highlighted with purple for Gimap3 and orange for Gimap5. CB = 
Conserved box, CC = Coiled-coil domain, TM = Transmembrane domain.  
In rats, a naturally occurring Gimap5 null allele causes T cell 
lymphopenia and is a susceptibility factor for autoimmune mediated diabetes 
[253, 254]. In mice, three independent models for Gimap5 deficiency have 
been reported. The first published model was a germ line genetic ablation 
with dysregulation of all of the leukocyte lineages, characterized by severe 
anemia and T cell lymphopenia, and liver dysfunction [264, 273]. An almost 
identical phenotype was reported in a mouse model generated by embryonic 
stem cell mutagenesis that carries a homozygous missense mutation in 
Gimap5 rendering the protein unstable [274]. In contrast the third mouse 
model, another germ line genetic ablation, was reported to have a much 
milder phenotype [275]. A Gimap3 knock-out mouse was not available when 
this thesis was initiated, but a germ line genetic knock-out was published in 
2014. The Gimap3 knock-out does not exhibit a phenotype in the 
hematopoietic compartment under normal conditions [275]. However, 
Gimap3 deficient bone marrow was shown to perform poorly in repopulating 
the hematopoietic system after bone marrow transplantation 
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3 Aims of the study 
The purpose of the studies presented in this thesis was to investigate the 
basis for genetic regulation of tissue-specific mtDNA segregation phenotypes 
in mammals by utilizing the BALB/NZB heteroplasmic mouse model.  
 
The specific aims were: 
 
1. To test the role of Gimap3 in tissue-specific mtDNA segregation. 
 
2. To investigate the characteristics of Gimap3 and its paralog Gimap5 to 
elucidate their role in tissue-specific mtDNA segregation. 
 
3. To investigate the importance of mitochondrial fission for mtDNA 
segregation. 
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4 Materials and methods 
The materials and methods used in this thesis are presented in detail in the 
original publications (I-III), and summarized here. 
4.1 Ethical statements 
All the animal work presented in this thesis was approved by the national 
Animal Experiment Board and were performed under the following animal 
experiment project licenses: ESAVI/6615/04.10.03/2012 and ESLH-2009-
09824/Ym-23. The author of this thesis has competence for performing and 
designing animal experiments as defined in the European Union directive 
2010/63/EU and the Finnish government act and decree for the use of 
animals for scientific or educational purposes (564/2013). 
4.2 Mouse models animal housing 
4.2.1 Animal housing 
All the animals were housed under standard conditions applied by the 
University of Helsinki Laboratory Animal Center with ad libitum feeding and 
12 + 12 hour light/dark cycle. Animals were housed in random groups and 
sampled in random order. Both male and female mice were used in the 
analyses. 
4.2.2 BALB/NZB heteroplasmic mice 
The BALB/NZB heteroplasmic mouse model was created by cytoplasmic 
transfer to one cell recipient embryos, and carries the mtDNA haplotypes 
from Balb/c and NZB inbred laboratory mouse strains [149]. They have been 
backcrossed and maintained on the Balb/c nuclear background for 20 years 
since their generation, and exhibit no known pathology. The heteroplasmic 
mice used in this thesis were derived from our own colony. 
4.2.3 Cast Gimap3 transgenics 
The generation of the Cast Gimap3 transgenic mouse model was part of the 
work described in this thesis. The coding sequence the Cast/Ei Gimap3 allele 
was cloned into the EcoRI site of pBroad3 vector (Invivogen) and 
microinjected to FVB embryos at the University of Helsinki Laboratory 
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Animal Center’s transgenic unit. The resulting chimeras were bred to Balb/c 
mice for further analysis. 
4.2.4 Gimap5 knock-out 
The Gimap5 knock-out strain (Gimap5tm1Wlr) was generated by targeted 
deletion of exon 2 and part of exon 3 of the mouse Gimap5 gene. The deleted 
are contains the initiation sequence for translation. The Gimap5 KO strain 
on Balb/c nuclear background was obtained through collaboration with 
Professor Hartmut Weiler (Blood Research Institute, Blood Center of 
Wisconsin, Milwaukee, United States) and the mice used this thesis were 
produced in our colony. 
4.2.5 Python mouse 
The Python mouse model (Dnm1lPy) harbors a C to T transversion in exon 11 
of Dnm1l gene that leads to substitution of a conserved cysteine at amino 
acid position 452 to phenylalanine [276]. This mutation is dominant-
negative, and homozygosity for the Dnm1lPy allele is lethal during embryonic 
development. The Python mouse was identified in a mutagenesis screen for 
cardiomyopathy. We obtained the Python mouse model on C57BL/6 nuclear 
background through collaboration with Professor Neil Dear (South 
Australian Health and Medical Research Institute, Adelaide, Australia). The 
animals used in this thesis were produced in our own colony and were either 
F1 crosses to the BALB/NZB heteroplasmic mouse model or N2 backcrosses 
of those F1 females to Balb/c males. 
4.2.6 Mouse crosses 
F2 generation from BALB/NZB heteroplasmic x M. m. castaneus intercross 
was produced by crossing female BALB/NZB heteroplasmic to male M. m. 
castaneus mice. Animals from the resulting F1 generation were bred with 
each other (F1 x F1) to produce F2 generation, referred to in the results 
section as F2 (BALB/NZB heteroplasmic x Cast/Ei). 
F2 generation  from the cross BALB/NZB heteroplasmic x Cast Gimap3 
transgenics was produced by breeding the founder of the Cast Gimap3 
transgenic (on a FVB background) with Balb/c animals to produce the F1 
generation. Males from the F1 generation were bred to BALB/NZB 
heteroplasmic females to produce the F2 generation data set referred to in 
the results section as F2 (BALB/NZB heteroplasmic x Cast Gimap3). 
N2 generation from the cross BALB/NZB heteroplasmic x Python mouse 
was generated by breeding female BALB/NZB heteroplasmic mice to male 
Python mice. Females of the resulting F1 generation were bred to C57BL 
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males to produce the N2 generation referred to in the results section as N2 
(BALB/NZB heteroplasmic x Python). 
4.2.7 Genotyping  
The mice used in this thesis were genotyped from DNA extracted by 
isopropanol precipitation from ear punches. The Cast Gimap3 transgenic and 
Gimap5 KO mice were genotyped by PCR and agarose gel electrophoresis. 
The Python mice were genotyped by PCR and restriction with ApoI enzyme 
(New England Biolabs), followed by agarose gel electrophoresis. The 
BALB/NZB heteroplasmic mice were genotyped by last cycle radioactive PCR 
and restriction fragment length polymorphism (RFLP) analysis by 
polyacrylamide gel electrophoresis, see 4.3.2 for details. The primers for 
genotyping are listed in Table 2. 
Table 2 Primer sequences and product sizes for genotyping genetically modified mice. * 
Product sizes refer to digestion products with Apo1 for Python and RsaI for BALB/NZB 
heteroplasmic mice. F=forward, R=reverse). 
Strain Primers 
Product size in bp 
Wild 
type Modified 
Cast Gimap3 
transgenic 
F: CATACCGTCACACCATCTGC 
R: CTTTTACCGCAGCCAGATTT 
1700 320 
Gimap5 KO 
WT F: CCAGAAGCCCACTGTGTAGAAGAAT 
KO F: TCCAGACTGCCTTGGGAAAAGC 
R: GTGAGAAGAGTCAAACCAAGCACAAT 
845 674 
Python* 
F: GCAGAGGATCATTCAGAATT 
R: TGGCATTTCAAATCAGTGTCAGG 
100 80 
BALB/NZB 
heteroplasmic* 
F: GAGCATCTTATCCACGCTTCC 
R: CTGCTTCAGTTGATCGTGGGT 
(BALB) 
218, 170 
& 121 
(NZB) 
339 & 
170 
 
4.3 DNA analyses 
4.3.1 DNA extraction 
Tissue pieces were snap frozen in liquid nitrogen upon collection and stored 
in -20 ºC prior to DNA extraction. The tissues were lysed overnight at +55 ºC 
in buffer (20 mM Tris-HCl, 5 mM EDTA, 1% SDS, 400 mM NaCl) containing 
0.2 mg/ml proteinase K. The DNA from lysate was extracted by standard 
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phenol-chloroform extraction and resuspended in sterile TE-buffer (pH 8). 
The DNA samples were stored at +4 ºC. 
4.3.2 Heteroplasmy analysis 
The relative heteroplasmy level was measured as the proportion of the NZB 
mtDNA genome RFLP analysis. The RFLP analysis is based on the RsaI 
restriction enzyme site at nucleotide position 3691 unique to the NZB 
genome. The area containing the polymorphism was amplified by PCR and 
32P (alpha) labeled dCTP added to the reaction for the last cycle. The PCR 
product was digested with RsaI (Roche) and separated on non-denaturing 
PAGE. The gel was dried and exposed to Storage Phosphor screen and the 
signal detected and quantified with a Typhoon 9400 laser scanner. Four 
bands (table 3) from the heteroplasmic mice can be detected: band 1 is 
unique to NZB and bands 2 and 4 unique to BALB. Band 3 shared and 
therefore omitted from analysis. The relative signal of band 1 was used to 
calculate the heteroplasmy level of NZB (equation 1). For tissue heteroplasmy 
analysis, each sample was run in duplicates. For genotyping of animals from 
ear punches a single reaction was analyzed.  
 
(1) ?? ?? ? ?????? ??????????????????????????????? ? ???? 
The selection against the NZB genome in the hematopoietic tissues was 
modeled as the proportion of NZB mtDNA variant left in the tissue at the 
given time point as described in [235]. To estimate this the percentage of 
NZB in the hematopoietic tissues relative to the percentage in a neutral tissue 
of the same animal was calculated. The neutral tissue is used as an 
approximate what the percentage of NZB was initially in the hematopoietic 
tissues, since at birth the heteroplasmy level is similar across tissues. The 
selection for the NZB genome in the liver and kidney was modeled as a 
relative fitness for the NZB genome, as described in [234]. The relative 
fitness calculation uses a population genetics equation that compares two 
asexual populations after n generations to estimate the relative advantage of 
the NZB genome according to equation 2, where p and q represent the 
frequency of NZB and BALB respectively, w/w1 the relative fitness and n the 
number of generations. To calculate the number of generations, mtDNA half-
life in liver and kidney was assumed to be similar to that experimentally 
determined for rats [277]. 
(2)  ?? ??? ? ? ?? ???? ? ??? ?????  
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4.3.3 MtDNA quantity 
4.3.3.1 Quantitative PCR 
The quantity of mtDNA was determined relative to a single copy nuclear gene 
β-2-microglobulin. The quantitation was performed with SYBR Green qPCR 
kit (Kapa Biosystems) on a Bio-Rad CFX96 thermal cycler. All the samples 
were run in technical triplicates.  
4.3.3.2 Southern blotting 
The DNA was digested with the NcoI restriction enzyme (New England 
Biolabs) and run on 0.8% agarose gel by electrophoresis. Subsequently the 
DNA was transferred to Hybond-XL membrane by alkaline transfer. The 
membrane was consecutively hybridized with a 32P (alpha) labeled nuclear 
probe against the 18S gene and mtDNA probe. The radioactive signal was 
recorded on a storage phosphor screen and imaged with a Typhoon 9400 
scanner. The relative intensity of mtDNA signal to nDNA signal was 
calculated with ImageQuant program. 
The hybridization conditions were the following. The membrane was 
prehybridized in 7% SDS, 0.25M sodium phosphate, 0.24M NaCl and 1mM 
EDTA at +42 ºC for one hour. The hybridization buffer (as prehybridization 
except for 50% formamide) and the labeled probe were added after 
prehybridization the membrane allowed to hybridize at 42 ºC overnight. The 
membrane was then washed with 2 X SSC, 0.1% SDS for one hour, 0.2 X SSC, 
0.1% SDS for 30 minutes and 0.1 X SSC, 0.1%SDS for 20 minutes at 37 ºC. 
4.4 RNA analyses 
4.4.1 RNA extraction 
Tissues were snap frozen in liquid nitrogen upon sample collection and 
stored at -80 ºC. For RT-PCR analysis, tissue pieces were homogenized in 1 
ml of Trizol reagent (Invitrogen) with PT Polytron 1200 E power 
homogenizer and the RNA isolated according to manufacturer’s instructions 
for Trizol. To isolate total RNA for northern blotting the frozen tissue 
homogenized with Precellys 24 tissue homogenizer (Bertin technologies) 
with mixed beads and a homogenization cycle of 5500 rpm for 25 sec in 1 ml 
of Trizol reagent and RNA isolated as in manufacturer’s instructions with the 
following modifications to minimize RNA degradation: 1) the dissociation 
step was performed on ice instead of room temperature, 2) the isopropanol 
precipitation was performed on ice 1 hour and 3) the ethanol wash of the 
pellet was done overnight at -20 ºC. All RNA samples were resuspended in 
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DEPC treated sterile water and treated with DNase I (New England Biolabs) 
prior to use in downstream applications and stored at -80 ºC. 
4.4.2 Northern blotting 
15 μg of total tissue RNA was separated on a 1.2 % agarose-formaldehyde gel 
and transferred by neutral transfer to Hybond N+ membrane (GE 
Healthcare). The membrane was UV cross-linked and used for hybridization. 
The probes for Gimap3 and Atp5b were end labeled with 32P (gamma) with 
T4 polynucleotide kinase (New England Biolabs) and purified with Illustra 
ProbeQuant G-50 microcolumns (GE Healthcare). The membranes were 
prehybridized in hybridization buffer (25% formamide, 7% SDS, 1% BSA, 
0.25 M sodium phosphate pH 7.2, 1 mM EDTA pH 8.0, 0.25 M NaCl) at 65 
ºC for 1 hour prior to addition of the probe. After probe addition, the 
temperature was lowered to 37 ºC and the hybridization allowed to proceed 
overnight. The membranes were consecutively washed with 2 x SSC, 0.1% 
SDS, 1 mM EDTA and 0.2 x SSC, 0.1% SDS, 1 mM, dried and exposed to 
Storage Phosphor screens, which were scanned and quantified with a 
Typhoon 9400 laser scanner. 
4.4.3 Reverse transcriptase PCR (RT-PCR) 
RNA levels expression of Gimap3 was investigated with Qiagen’s one-step 
RT-PCR kit with primers amplifying over exon 4, which is present in Balb 
Gimap3 but absent from Cast Gimap3 mRNA. The corresponding product 
sizes detected on AGE are 462 bp and 427 bp, respectively. To semi 
quantitatively analyze the allelic expression of Gimap3 in F2 (Balb/c x 
Cast/Ei) the RT-PCR was compared to a standard curve generated with 
equimolar mixtures of Balb/c and Cast/Ei RNA (r2=0.97). The signals were 
quantified with a Typhoon 9400 laser scanner. 
4.5 Protein analysis 
4.5.1 Immunoblotting and histodenz gradients 
Tissue samples for protein analysis were snap frozen in liquid nitrogen upon 
collection and stored at -80 ºC. For immunoblotting, samples were 
homogenized in buffer (HIM: 200 Mm mannitol, 70 mM sucrose, 10 mM 
HEPES, 1 mM EGTA pH 7.5) with a Teflon pestle homogenizer and 
centrifuged at 20 000 x g for 30 minutes. The resulting pellet was used for 
protein solubilization. To obtain protein samples from splenic leukocytes 
freshly collected spleens were dissected in PBS and pressed through 70 nm 
cell strainer. The resulting cell suspension was washed with PBS and pipetted 
 49 
through a fresh cell strainer. The cells were pelleted and the pellet used for 
solubilization. For protein samples from cultured cells, the cells were scraped 
off the tissue culture plates and pelleted by centrifugation and the pellet 
washed with PBS. The washed pellet was used for solubilization. Proteins 
were solubilized with 1% DDM, 1 x complete mini protease inhibitor, 1 mM 
PMSF in PBS for 20 minutes on ice. The samples were the centrifuged at 20 
000 x g at +4 ºC for 30 minutes. The supernatant was collected and used as 
total protein sample. Samples were stored in -80 ºC. 
Protein concentration was determined by the Bradford method and equal 
amounts of protein sample in Laemmli sample buffer separated on SDS-
PAGE. The proteins were transferred onto a membrane by semidry transfer, 
and the membranes blocked with 1% milk in TBS-T. The primary antibodies 
(Table 3) were incubated at +4 ºC overnight. Antibody detection was by 
secondary HRP conjugates and enhanced chemiluminescense (Cell signaling 
technologies). The membranes were exposed to medical X-ray film or imaged 
with a BioRad Chemidoc imaging station. When western blots were 
quantified, the Chemidoc imaging station was used. 
For Histodenz gradients mouse spleens were homogenized in HIM-buffer 
with a Teflon pestle homogenizer and centrifuged twice at 600 x g at +4 ºC 
for 10 minutes. The resulting post nuclear suspension was subsequently 
mixed with an equal volume of 50% of Histodenz (Sigma) and separated on a 
discontinuous sucrose gradient by centrifugation at 52 000 x g at +4 ºC for 
90 minutes. Samples were collected and TCA precipitated, and analyzed by 
SDS-PAGE and immunoblotting. 
Table 3 Antibodies used in immunoblotting. Balb and Cast Gimap3 antibodies are 
polyclonal antibodies raised in rabbits. Other antibodies are commercial. 
Antibody Company  Raised against peptides (amino acids) 
Balb Gimap Biogenes 
ETLQNVVTGGKKGGC (2 – 16) 
CEGSWVLKVLPIGKK (269 – 272) 
Cast Gimap3 Biogenes RIPVYTTDHLRCPDS (32 – 45) 
Calnexin Proteintech Group NA 
Tom40 Santa Cruz NA 
Atg5 Sigma NA 
Sdha Mitosciences NA 
Porin Millipore NA 
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4.5.2 Isobaric tags for relative and absolute quantification (iTRAQ) 
analysis 
ITRAQ analysis is based on chemical tags with stable isotopes for relative 
quantification of peptides identified by mass-spectrometry (MS). The tags 
are of equal mass but contain specific reporter groups based on N-
methylpiperazine that can be detected by LC-MS/MS (liquid 
chromatography-mass spectrometry/mass spectrometry). In our analysis we 
used three tags with different reporter groups to analyze the relative 
abundance of peptides between three samples. The iTRAQ analysis was 
performed on protein obtained from membrane enriched spleen samples. 
The membrane enrichment work flow is depicted in Figure 8. 120 μg of 
solubilized protein from the membrane enrichment was precipitated with 2-
D Clean Up kit (GE-healthcare). The protein samples were trypsinized, 
labeled with the iTRAQ labels and analyzed by LC-MS/MS. Three biological 
replicates were included for each genotype.  
 
Figure 8 Subsequent centrifugation steps to obtain a pellet enriched in the cellular 
membrane fraction for protein solubilization 
4.5.3 In vitro translation 
Proteins were synthesized with TNT T7 reticulocyte lysate system (Promega) 
from the following constructs: A) YFP with N-terminal fusion of the Cast 
Gimap3 amino acids 1 – 68, B) amino acids 1 – 68 of Cast Gimap3, C) Balb 
Gimap3 coding sequence, D) Cast Gimap3 coding sequence and E) YFP. All 
the constructs were cloned in pCDNA3.1 vector. The optimal reaction time 
for the in vitro translation with (35S)Met-Cys was determined linear 
radiolabel incorporation to YFP and was 25 minutes. The samples were then 
separated by SDS-PAGE, the gel dried and the radioactive signal detected 
and quantified with a Typhoon 9400 laser scanner. 
4.6 Blood analysis 
Whole blood sample was collected by cardiac puncture immediately after 
euthanasia into 1 ml syringes with a 25 gauge needle. The blood was 
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transferred into EDTA coated tubes and analyzed within 24 hours with Advia 
2120i analyzer at the University of Helsinki Small Animal Hospital. 
4.7 Cell culture and microscopy 
Cell lines (MEFs, COS-7 and NIH3T3) were cultured under standard 
conditions in DMEM supplemented with 10% FBS and Glutamax. 
4.7.1 Generation of murine embryonic fibroblasts (MEFs) 
To generate MEFs with the Python mutation in the Dnm1l gene, C57BL/6 
females were bred to C57BL/6 male carrier of the Python mutation. The 
embryos were collected from euthanized females at E13.5, and a single cell 
line established from each embryo. The embryos were dissected and 
incubated for 60 – 90 minutes at +37 ºc in 1 X Trypsin-EDTA in PBS, and 
the suspension was mixed repeatedly during incubation. The Trypsin in the 
resulting cell suspension was inactivated with FBS, and the cells washed with 
medium. The cells were plated on cell culture dishes in DMEM supplemented 
with 10% FBS, Glutamax, Penicillin and Streptomycin, and allowed attach. 
Once the cells reached confluency, they were passaged and sample for 
genotyping obtained. Genotyping of the cell lines was as for Python mice 
(4.2.6, table 4). 
4.7.2 Transient transfection and retroviral transduction 
Constructs for transient transfections were cloned into the pCDNA3.1 vector 
and transfected to cells with jetPRIME transfection reagent (Polyplus). The 
GFP-Sec61β used for transfection was received as gift from Professor Benoit 
Kornman (ETH Zürich, Institute for Biochemistry, Switzerland). For 
generation of stable cell line through retroviral transductions constructs were 
cloned into Gateway converted retroviral expression vectors (pBABE-puro, 
pMYS-IRES-Neo, or pMXs-IRES-Blasticidin). The pGFP-Omp25 was 
received as a gift from Professor Hans Spelbrink (Nijmegen Center for 
Molecular Life Sciences, Institute for Genetic and Metabolic Disease, the 
Netherlands). For virus production the plasmids were transfected into 
Phoenix A packaging cell line. The virus was collected and used to transduce 
recipient cell lines, which were subjected to selection with the appropriate 
antibiotic prior to use in experiments. 
4.7.3 Cell fixation and antibody staining 
Cells were grown on cover slips and fixed with 4% paraformaldehyde for 10 
minutes. For antibody staining, cells were permeabilized 0.2% Triton X and 
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blocked with 5% BSA for two hours. The primary antibody was incubated 
overnight at +4 ºc. The secondary Alexa fluorophore conjugated antibody 
was incubated for one hour, and the cover slips mounted onto a microscopy 
slide with Dabco/Mowiol 4-88. 
4.7.4 Microscopy 
Microscopy slides were imaged with a Leica TCS  Sp8 CARS (Coherent Anti-
Stokes Raman Scattering) microscope with 633 APO (1.2 numerical 
apperture (NA)) water objective using the Argon (488 nm) and DPSS (561 
nm) lasers or Zeiss META 510 with the 633 Plan-Apochroma (1.4 NA) 
objective using the Argon (488 nm) and HeNe1 (543 nm) lasers. Image 
processing was performed with ImageJ program. Only linear corrections 
were applied during processing. 
 
4.8 Statistical analysis 
Statistical analysis was performed with Statplus or GraphPad Prism 6 
programs. To analyze differences in between the means of groups analysis of 
variance (ANOVA) or two-tailed T-test was used, depending on the number 
of groups in the comparison. To test for difference in variances between the 
groups, F-test was used. All data sets were tested for normality prior to use of 
parametric statistic tests. When data did not follow normal distribution, 
nonparametric test (Mann-Whitney U test) was used. 
Nonlinear regression analysis was performed in GraphPad prism with 
default parameters (least squares fit). The line was constrained to go through 
the origin to determine the best fit slopes for each data set. The goodness of 
fit estimated with r2 values, and a runs test was performed on the residuals to 
evaluate whether the fitted line deviates systematically from the data.  
The Kimura distribution analysis for neutral mtDNA transmission was 
done in collaboration with Dr. James Stewart (Max Planck Institute for 
Biology of Ageing, Cologne, Germany). The analysis was done as described in 
[202] and publication III. 
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5 Results 
5.1 Gimap3 is a genetic modifier of tissue-specific 
mtDNA segregation in mice (I) 
5.1.1 Genetic mapping of a candidate gene for tissue-specific mtDNA 
selection 
At the time when this thesis was initiated, not a single gene involved in 
tissue-specific mtDNA segregation in mammals had been identified and 
Smdq1-3 represented the only mapped nuclear loci. However, a linkage study 
to identify candidate genes had already been conducted, and was later 
published as a part of publication I of this thesis. Therefore, it is appropriate 
to summarize the results of the linkage study here, even though it preceded 
the work done for this thesis. 
In the BALB/NZB heteroplasmic mice, there is age-dependent selection 
against the NZB genome in the hematopoietic tissues. This selection 
phenotype can be progressively lost with backcrossing to Cast/Ei 
background, indicating regulation by a limited number of nuclear-encoded 
genes [235, 240]. F2 (BALB/NZB heteroplasmic x Cast/Ei) animals of 
intercrosses between the BALB/NZB heteroplasmic mice and Cast/Ei mice 
(see section 4.2.6 details of the cross) can be sorted into two groups: animals 
where selective mtDNA segregation is lost ((-) selection group) and animals 
where selective mtDNA segregation occurs ((+) selection group). At the age 
of one year, six percent of the animals exhibited no selection against the NZB 
genome. A genome wide linkage analysis was performed in one-year-old F2 
(BALB/NZB heteroplasmic x Cast/Ei) animals a single statistically significant 
locus on chromosome 6 was identified. This locus is within the previously 
mapped nuclear regulator of mtDNA segregation in the spleen, Smdq-3 
[240], but this new linkage analysis narrowed down the size of the locus to 11 
megabases. This locus contained six genes with putative mitochondrial roles 
(Table 4). Sequencing of the full-length mRNA of these six genes revealed a 
major splicing difference in Gimap3 (detailed in section 5.1.2). Moreover, 
Gimap3 and Gimap5 were the only genes in the group with expression 
restricted to hematopoietic tissues. Therefore we hypothesized that Gimap3 
affects mtDNA segregation in the spleen and prioritized this gene for further 
investigation.  
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Table 4 Genes within the locus identified by linkage analysis with putative roles in 
mitochondrial biology. 
Gene Function 
Adck2 Kinase of unknown function 
Ndufb2 Respiratory chain complex 1 subunit 
Mrps33 Mitochondrial ribosome protein 
Gstk1 Protein disulfide oxidoreductase 
Gimap5 Immune related GTPase 
Gimap3 Immune related GTPase 
5.1.2 A splicing defect in the Cast/Ei Gimap3 allele 
In both M. m. domesticus and M. m. castaneus the Gimap3 gene consists of 
five exons. The mRNA from the allele present in Balb/c and other M. m. 
domesticus laboratory mouse strains, denoted from here onwards as Balb 
Gimap3, contains all of the five exons and two AUG sites for the initiation of 
translation. The first AUG site is located in exon 3, and the second in exon 4. 
The second start site in exon 4 is also preceded by a stop codon, and the 
mature Gimap3 is a polypeptide produced by translation utilizing the second 
AUG site in exon 4 with a predicted size of 31 kDa (Figure 9). In contrast, in 
Cast/Ei mice a G to A transition in the splice acceptor site of exon 4 is 
present and exon 4 is absent from the mature mRNA (Figure 9). This allele is 
referred to as Cast Gimap3. The mature Cast Gimap3 protein is translated 
from the alternative AUG site in exon 3, and produces a polypeptide with a 
predicted size of 41 kDa. The two variants, Balb and Cast Gimap3, are 
identical within all of the conserved protein domains of Gimap3, but the Cast 
Gimap3 has an extra 58 amino acids in the N-terminus of the protein (Figure 
9). 
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Figure 9 Schematic presentation of the exons of the Gimap3 gene, mRNA and protein 
structure in Balb/c and Cast/Ei mice. The coding sequence and the differentiating 
feature between the subspecies, exon 4, are color coded. Black arrows above the 
exons indicate translation start sites. Conserved domains in the protein are color 
coded and indicated above (P-loop=GTPase domain CB= conserved box, 
CC=coiled coil, TM=transmembrane). The location of the extra amino acids present 
in the Cast Gimap3 protein is colored by orange. 
To test whether the Cast Gimap3 allele is enriched within the group of F2 
(BALB/NZB heteroplasmic x Cast/Ei) animals where the selective mtDNA 
segregation is lost we investigated the allele distribution of Gimap3 between 
the (+) selection group and (-) selection group (defined in section 2.4.3). The 
genotype distributions between the groups were significantly different from 
those predicted by Mendelian ratios (p<0.01, χ2 –test), with enrichment of 
the Cast Gimap3 allele in (-) selection group. 
5.1.3 Generation of Cast Gimap3 transgenic mice 
To experimentally study the role of Gimap3 in mtDNA selection, a transgenic 
model expressing the Cast Gimap3 allele on a Balb/c nuclear background 
was generated. The cDNA of the Cast Gimap3 coding sequence driven off the 
ubiquitous promoter ROSA26 [278, 279] was microinjected into embryos 
and gave rise to seven chimeric founder lines. Of the seven only four 
transmitted the transgene to their offspring, and this transmission did not 
differ from expected Mendelian ratios as determined by χ2 –square test.  
The transgene expression in these lines was assessed by reverse 
transcriptase PCR. A primer set amplifying a region spanning over exon 4, 
which is missing in the Cast Gimap3 mRNA, allows detection of mRNA from 
both Gimap3 alleles simultaneously as they produce PCR products that differ 
in size by 35 base pairs. One of the founder lines was found to exhibit 
reproducible and robust expression of the transgenic Cast Gimap3 allele in a 
variety of tissues (Figure 10). This line was selected for further experiments, 
and is referred to as the Cast Gimap3 transgenic strain. The endogenous Balb 
Gimap3 allele was detected in the spleen sample of the Cast Gimap3 
transgenic strain as well as in the parental strain, but was absent from other 
tissues investigated consistent with previous reports [248]. 
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Figure 10 Expression of Balb and Cast Gimap3 alleles by RT-PCR. S=spleen, H=heart, 
B=brain and L=lung. 
5.1.4 Transgenic expression of Cast Gimap3 modifies mtDNA 
selection in the spleen 
To test the role of Cast Gimap3 in mtDNA selection, we crossed the Cast 
Gimap3 transgenic mice with the BALB/NZB heteroplasmic mouse model, 
and analyzed the tissue distribution of heteroplasmy in the F2 (BALB/NZB 
heteroplasmic x Cast Gimap3) generation (see section 4.2.6 for details of the 
cross). Tissues were collected at the age of three months, where normally the 
relative level of the NZB genome approaches 50% of the initial heteroplasmy 
level. We analyzed the level of reduction in the relative level of the NZB 
genome by comparing the percentage of NZB genome in the spleen to the 
percentage in tissues with neutral mtDNA segregation, where the 
heteroplasmy level does not change with age. In such analysis a value of 1.0 
would indicate that the relative level of the NZB genome has not changed, 
whereas 0.0 would indicate that the NZB genome had been selected away 
completely. We observed that the relative level of NZB decreased 
significantly less in the spleen of transgenic animals expressing the Cast 
Gimap3 than in the transgene negative litter mate controls, or in the 
BALB/NZB heteroplasmic mouse model under pure Balb/c nuclear 
background (ANOVA p<0.01). The transgene negative F2 (BALB/NZB 
heteroplasmic x Cast Gimap3) animals were indistinguishable from the 
animals on the pure Balb/c background, showing that the observed 
difference was not due to mixed nuclear background (Figure 11). 
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Figure 11 The proportion of the NZB mtDNA variant in the spleen relative to the neutral 
tissues in the BALB/NZB heteroplasmic animals on pure Balb/c nuclear background 
(Balb/c, n=23) and in F2 animals either negative (F2 Tg neg, n=16) or positive (F2 
Tg pos, n=17) for the Cast Gimap3 transgene. The line indicates the mean. 
To examine whether expression of Cast Gimap3 affects the mtDNA 
selection phenotypes seen in other tissues we examined the heteroplasmy 
level in the liver and kidney of transgenic positive and negative animals. The 
mtDNA selection in these tissues is best modeled with a relative fitness value, 
which estimates the selective advantage of the NZB genome [234]. 
Expression of Cast Gimap3 did not cause any statistically significant 
differences in the relative fitness of the NZB genome in either liver or kidney 
(Figure 12). Therefore Gimap3 is a tissue-specific genetic modulator of 
mtDNA selection in the hematopoietic tissues. 
 
Figure 12 Relative fitness of the NZB genome in liver and kidney. The data is presented as 
means with standard deviations, n=16 for transgenic negative and n=17 for the 
transgenic positive groups. 
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5.1.5 Gimap3 does not affect mtDNA copy number 
We next analyzed whether the modulatory effect of Gimap3 on mtDNA 
selection in the spleen was due to changes in mtDNA copy number. First we 
measured mtDNA quantity relative to nuclear DNA by qPCR in F2 
(BALB/NZB heteroplasmic x Cast/Ei) groups of (+) selection and (-) 
selection. There was no difference in the mean relative mtDNA copy number 
or in variance between these groups (Figure 13). Then we analyzed whether 
the expression Cast Gimap3 affects copy number, but there was no difference 
in the relative mtDNA quantity between the transgenic negative and positive 
litter mates (Figure 13, unpublished). Taken together, these data show that 
while Gimap3 modulates the mtDNA selection in the spleen, it does not 
affect mtDNA copy number at steady state. 
 
Figure 13 Relative mtDNA quantity determined by qPCR. In the left panel data from F2 
(BALB/NZB heteroplasmic X Cast/Ei) crosses, n=32 in the selection group and 
n=13 in the no selection group. In the right panel data from F2 (BALB/NZB 
heteroplasmic x Cast Gimap3) transgenics, n=7 in the Tg neg and n=12 in the Tg 
pos groups. Data is presented as means with standard deviations. 
5.2 Molecular studies of Gimap3 reveal complex 
expression regulation and a novel subcellular 
localization (I and II) 
5.2.1 Cast and Balb Gimap3 are differentially expressed in mice (I and 
II) 
To gain insight into how Gimap3 might be affecting the tissue-specific 
mtDNA selection in mice, we investigated the gene expression of the two 
alleles, Balb and Cast Gimap3. MRNA from both alleles can be detected by 
RT-PCR in the spleen of Balb/c and Cast/Ei animals, respectively (Figure 
10), but to definitely test the expression of mRNA originating from Gimap3 
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in the different subspecies we performed northern blotting with total RNA 
samples isolated from the spleen of Balb/c and Cast/Ei animals. Cell line 
controls stably expressing the coding sequence of Balb Gimap3 and the 
highly similar paralog, Gimap5, were included to control for probe 
specificity. We used three independent probes for Gimap3 and detected 
robust mRNA expression from both alleles with probes a and b (Figure 14). 
Probe c binds to the junction of exon 4 and exon 5 so only half of the probe 
sequence is present in the Cast Gimap3 mRNA. Correspondingly, stronger 
expression with this probe was detected from the Balb allele (Figure 14). In 
both subspecies, there appears to be three separate transcripts, the 
significance of which is at present unknown. 
 
Figure 14 RNA level expression of Balb and Cast Gimap3. On the left, northern blotting with 
Gimap3 probes a-c and control probe against Atp5B are shown, along with the 
ethidium bromide stained gel. On the right the location of the Gimap3 probes is 
illustrated above the Balb and Cast Gimap3 mRNA. The coding sequence is 
highlighted in purple and the locations of probes a – c are indicated above the 
graphic. The number of the exon is indicated below the graphic. 
We next analyzed the protein level expression from the two alleles using 
polyclonal antibodies raised against allele specific peptides in rabbit. Both 
Balb and Cast Gimap3 can be expressed in cultured cells via retroviral 
transduction, and the protein detected with our antibodies. As a control for 
the antibodies we included a cell line expressing both variants 
simultaneously (Figure 15). To our surprise, we could not detect Cast Gimap3 
protein in the spleen of Cast/Ei mice, or in the F2 (BALB/NZB heteroplasmic 
x Cast/Ei) crosses heterozygous for the locus (Figure 15). In contrast, the 
Balb Gimap3 protein was expressed in Balb/c animals and detected in the F2 
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(BALB/NZB heteroplasmic x Cast/Ei) animals, albeit in reduced quantity to 
the parental strains (Figure 15). Based on these results the mature Gimap3 
protein in mice is only produced from the Balb Gimap3 allele. Furthermore 
there appears to be a gene dosage effect on the protein abundance, as F2 
(BALB/NZB heteroplasmic x Cast/Ei) animals heterozygous for the Gimap3 
allele exhibited reduced protein quantity by comparison to the parental 
Balb/c strain.  
 
 
Figure 15 Western blotting with indicated antibodies of protein samples isolated from the 
spleen of Cast/Ei, Balb/c and F2 (BALB/NZB heteroplasmic x Cast/Ei) mice. Atg5-
Atg12 and Tom40 antibodies were used as loading controls. BXC stands for 
BALB/NZB heteroplasmic x Cast/Ei. The control NIH3T3 cell line expresses epitope 
tagged versions of both Balb and Cast Gimap3 proteins ectopically. 
5.2.2 A potential role for an upstream open reading frame in the 
regulation Gimap3 translation (II) 
The Balb Gimap3 gene contains an upstream open reading frame (uORF) 
sequence, which in the Cast Gimap3 variant is a part of the coding sequence 
and codes for a amino acid sequence in the N-terminus of the Cast Gimap3 
protein (referred to as the CAST(1-68) fragment).  This fragment is not present 
in the Balb Gimap3 protein. Translation from the upstream open reading 
frame can act as a post-transcriptional regulator of expression [280, 281]. To 
investigate whether translation regulation mediated by the Balb Gimap3 
uORF underlies the differential expression of the Balb and Cast Gimap3 
allele observed in mice, we analyzed the translation of the two alleles and a 
marker protein YFP with or without the presence of the CAST(1-68) fragment 
fragment with an in vitro translation assay (Figure 16). The constructs used 
in this analysis are listed in Table 5. The CAST(1-68) fragment (B) could not be 
detected on its own, and incorporation of this fragment to YFP (A) reduced 
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translation by comparison to YFP alone (E). Reduced translation was also 
observed from the Cast Gimap3 allele (D) by comparison to the Balb Gimap3 
allele (C), confirming that the sequence encoding for the CAST(1-68) fragment 
can repress translation in vitro when incorporated into the coding sequence.  
 
Table 5 Constructs used in in vitro translation analysis. 
A CAST(1-68) fragment + YFP 
B CAST(1-68) fragment 
C Balb Gimap3 CDS 
D Cast Gimap3 CDS 
E YFP 
 
 
Figure 16 Analysis of in vitro translation of the CAST(1-68) fragment fused to YFP (A), the 
CAST(1-68) fragment alone (B), the Balb Gimap3 coding sequence (C), the Cast 
Gimap3 coding sequence (D) and YFP (E). The signal intensity was quantified for 
construct A relative to construct E, and construct D relative to construct C. 
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In the in vitro analysis of the YFP fused with the CAST(1-68) fragment, 
most of the protein co-migrated at the molecular weight of the full construct 
but weaker bands of smaller size were observed. One of these corresponded 
in size with YFP. To further investigate this observation we expressed the 
same constructs in cultured cells, and observed that the majority of the 
protein detected with the YFP antibody corresponded to the size of YFP, 
whereas only a small fraction was detectable by overexposure to the full 
length construct. This difference between the in vitro translation and in vivo 
suggests that a more complex regulation with additional factors takes place 
in living cells. 
A stalled ribosome can cause translational repression, and is one of the 
mechanisms underlying regulation of translation by uORFs [280, 281]. 
Stalled ribosomes activate cellular pathways that lead to the degradation of 
the polypeptide on the stalled ribosome by the proteasome (reviewed in 
[282]). Three lines of evidence show that ribosome stalling occurs at 
sequence encoding for the CAST(1-68) fragment. First, the smearing observed 
in the in vitro translation of YFP with the CAST(1-68) fragment (Figure 16), 
could be indicative of stalled ribosomes. Second, accumulation of smaller 
molecular weight peptides was detected in cells expressing the YFP with the 
CAST(1-68) fragment in the presence of a proteasomal inhibitor. Last, 
proteasomal inhibition increased the association of the CAST(1-68) fragment 
containing YFP with the assembled ribosome, indicating that the CAST(1-68) 
fragment can induce proteasome dependent degradation when on the 
ribosome (for details of the experiments with proteasomal inhibition, see 
publication II). 
These data show that the Balb Gimap3 uORF sequence, when 
incorporated to the coding sequence in Cast Gimap3, is capable of repressing 
translation, which can explain the lack of mature protein in Cast/Ei mice. 
This phenotype is detectable in vitro and further modified in vivo, indicating 
the involvement of multiple factors. Upstream open reading frames are 
common in mammalian mRNAs, and have been previously described for 
proteins involved in immune response [280, 283]. Such a regulatory 
mechanism facilitates rapid responses in protein expression level, and 
therefore it is possible that Gimap3 in vivo responds to immunological 
signals. Yet based on our data that Cast/Ei mice lack almost any detectable 
Gimap3 protein at the steady state level, it appears to be dispensable under 
conditions where the immune system is not challenged. These results are 
consistent with the recently published Gimap3 knock-out mouse that has no 
phenotype under normal conditions, demonstrating that Gimap3 is not 
essential for life or embryonic development [275]. 
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5.2.3 The expression level of Gimap3 associates with the mtDNA 
selection phenotype (II) 
To analyze whether the expression level differences we uncovered correlate 
with the mtDNA selection phenotype in the mice, we analyzed the relative 
mRNA expression level from each allele in F2 (BALB/NZB heteroplasmic x 
Cast/Ei) groups of (+) selection and (-) selection, where Gimap3 was 
originally identified as a candidate gene by linkage analysis. We used semi-
quantitative RT-PCR and observed a significantly stronger relative 
expression from the Balb Gimap3 allele in the (+) selection group of mice 
than in the (-) selection group. As the mature protein is only produced from 
the Balb Gimap3 mRNA it is likely that it is the abundance of mature Balb 
Gimap3 protein is a critical factor affecting the mtDNA selection phenotype. 
Transgenic expression of the Cast Gimap3 coding sequence in the 
BALB/NZB heteroplasmic mouse model reduced the rate of mtDNA 
segregation in the spleen (Figure 11). How this effect was mediated is 
unclear, given that no mature protein produced from this template is 
detected in vivo in mice. It is possible that transgenic expression of Cast 
Gimap3 mRNA affects the abundance of endogenous Balb Gimap3 mRNA 
through some feedback regulation, and thus affects mtDNA segregation 
through the abundance of Balb Gimap3. However, the abundance of Balb 
Gimap3 mRNA was not quantitatively examined. 
5.2.4 Gimap3 is a resident endoplasmic reticulum protein (II) 
A single report placed Gimap3 on the outer mitochondrial membrane [256], 
which was one of the criteria that helped to establish Gimap3 as the preferred 
candidate gene in modifying mtDNA segregation. However, we were unable 
to validate the mitochondrial localization of Gimap3 in our experiments and 
therefore we investigated the subcellular localization of Gimap3 in more 
detail. To analyze the localization of the endogenous Gimap3, we separated 
total protein samples isolated from the spleen of Balb/c animals on a 
histodenz gradient to determine with which markers of subcellular 
compartments Gimap3 co-sediments. Surprisingly, we consistently observed 
cosedimentation of Gimap3 with markers for the ER, while no co-
sedimentation was observed with either the outer mitochondrial membrane 
protein Porin, or the matrix protein Sdha.  
To further study the localization of Gimap3, we visualized Gimap3 
distribution in cultured cells with fluorescent light microscopy. 
Unfortunately our polyclonal Gimap3 antibody is ineffective in indirect 
immunofluorescent detection by light microscopy. Therefore cultured cells 
were cotransfected with Gimap3 tagged N-terminally with RFP and GFP- 
tagged markers for the ER and mitochondria, respectively, to visualize 
subcellular localization of this protein. We consistently observed 
colocalization of Gimap3 with the ER marker Sec61β. No colocalization with 
Omp25, a bona fide mitochondrial marker [284], was observed (Figure 17).  
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Figure 17 Confocal micrographs of COS7 fibroblast cells cotransfected with the indicated 
constructs. The scale bar indicates 10 μm. 
Ideally, fluorescent microscopy showing subcellular colocalization would 
be achieved with endogenous expression and with no tags. Unfortunately our 
polyclonal Gimap3 antibody is ineffective in fluorescent microscopy. 
Moreover, epitope tagged (HA and C-myc) versions of Gimap3 were also 
ineffective in immunofluorescence suggesting that the epitope might be 
inaccessible to antibodies (unpublished data). The localization of tail-
anchored membrane proteins has been shown to be dependent only on the 
transmembrane domain and flanking sequences (reviewed in [285]). For 
Gimap3, these sequences reside in C -terminus, so an amino-terminal RFP- 
tag did not affect correct localization. We were also able to show that the C-
terminal domain alone yielded similar subcellular distribution as the full-
length Gimap3, and replacing C-terminal sequence of Gimap3 with C-
terminal sequence of the mitochondrial marker Omp25 relocalizes the 
protein to mitochondria. Taken together, the sedimentation profile of 
endogenous Gimap3 and fluorescent imaging conclusively show that Gimap3 
localizes to endoplasmic reticulum. 
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5.3 Involvement of Gimap5 in tissue-specific mtDNA 
segregation (II) 
5.3.1 Heterozygous loss of Gimap5 modulates mtDNA segregation  
The initial linkage analysis that led to the cloning of Gimap3 as modifier of 
tissue-specific mtDNA segregation, could not distinguish between Gimap3 
and Gimap5 as these genes are in linkage. Although we have established a 
role for Gimap3 in modifying mtDNA segregation in the hematopoietic 
compartment, we also investigated a potential role for Gimap5. 
We took advantage of a germ line genetic knock-out mouse for Gimap5, 
Gimap5tm1Wlr, referred here to as Gimap5 KO [273]. The homozygous 
Gimap5 KO animals exhibit severe dysregulation of all of the hematopoietic 
lineages, with red blood cells, T cells and NK cells being the most severely 
affected. The genetic ablation does not affect the expression of other Gimap 
genes on the RNA level. Animals heterozygous for the Gimap5 KO allele, do 
not share any of the pathogenic phenotypes, but exhibit 50% decrease in the 
abundance of Gimap5 mRNA and/or protein – a gene dosage effect that is 
consistent between all of the three Gimap5 null mice reported [273-275]. We 
crossed the BALB/NZB heteroplasmic mice with the Gimap5 KO strain to 
generate heteroplasmic mice carrying the Gimap5 KO allele. Both strains 
were on a Balb/c nuclear background. We then analyzed the tissue specific 
segregation in the heterozygous and wild type litter mates, but the 
homozygous Gimap5 KO animals were excluded from this analysis due to 
potential confounding factors produced by the extensive hematological 
pathologies and differences in leukocyte numbers present in these mice. We 
observed that the relative proportion of NZB decreased significantly less in 
the bone marrow (p<0.01, two-tailed t-test) and spleen (p<0.05, two-tailed t-
test) of the heterozygous Gimap5 KO animals by comparison wild type 
controls (Figure 18). The variance between the groups was not significantly 
different in either tissue. This effect was specific to the hematopoietic tissues, 
as no significant difference in the mtDNA selection phenotype measured as 
relative fitness of the NZB genome in the liver was observed between the 
Gimap5 KO wild type (mean = 1.08721, standard deviation = 0.024, n = 17) 
and heterozygous (mean = 1.09749, standard deviation = 0.040, n = 17) 
animals. 
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Figure 18 MtDNA segregation in the bone marrow and spleen of Gimap5 KO heterozygous 
and wild type mice.  In the left panel, n=18 for both groups. In the right panel for the 
spleen, n=18 for the Gimap5 WT and n=20 for the Gimap5 HET group. A line 
indicates the mean of each data set. 
5.3.2 The abundance of Gimap3 and factors involved in actin 
cytoskeleton biology are dependent on Gimap5 
Gimap3 can modulate mtDNA segregation, and therefore we investigated 
whether the loss of Gimap5 affects the expression of Gimap3. We analyzed 
the expression of Gimap3 (which in these mice is the Balb Gimap3 variant) 
in the heterozygous Gimap5 KO animals. We detected similar mRNA level 
expression of Gimap3 in both the Gimap5 WT and Gimap5 HET animals by 
northern blotting from total spleen RNA. In contrast, the protein level as 
determined by Western blotting was surprisingly reduced by approximately 
50% (Figure 19).  
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Figure 19 Expression of Gimap3 in Gimap5 KO heterozygous and wild type animals. Panel A 
shows a representative northern blotting and quantification with probes against 
Gimap3 and Atp5B, and the ethidium bromide stained gel. In panel B, a 
representative western blot and quantification from splenic leukocytes is shown. In 
both panels, quantification results were standardized against a wild type value. 
To identify other factors affected by the heterozygous loss of Gimap5, we 
performed quantitative mass-spec (LC-MS/MS) analysis of the proteins 
isolated from the spleen. We isolated protein from homogenized spleens 
from three pairs Gimap5 KO wild type and heterozygous litter mates, which 
were used as three biological replicates for analysis by iTRAQ (isobaric tags 
for relative and absolute quantitation) mass spectrometry. In iTRAQ, the 
peptides of each sample are labeled with a distinct chemical tag that allows 
for relative quantitation of the peptides between the two samples (Gimap5 
KO heterozygous versus wild type) after identification of peptides by mass-
spec. Five proteins exhibited robust changes in abundance in the Gimap5 het 
animals (Table 6). Surprisingly, all of these proteins were involved in the 
regulation of actin cytoskeleton and cell motility (data retrieved from 
UniprotKB). 
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Table 6 Factors with quantitative changes in abundance iTRAQ analysis between Gimap5 
wild type and heterozygote animals. 
Protein Gene 
Fold 
change 
het/wt 
Biological process 
Cyfip2 
Cytoplasmic FMR1 
interacting protein 2 
0.55 
Component of WAVE complex 
for assembly of F-actin complex 
Arhgdia 
Rho GDP dissociation 
inhibitor (GDI) alpha 
0.57 
Rho protein signal transduction, 
regulation of protein localization 
Vasp 
Vasodilator-stimulated 
phosphoprotein 
0.57 
Actin cytoskeleton 
reorganization 
Elmo1 
Engulfment and cell 
motility 1 
1.83 
Actin filament-based process, 
phagocytosis 
S100A9 
S100 calcium binding 
protein A9 
2.12 
Actin cytoskeleton 
reorganization, leukocyte 
chemotaxis, phagocytosis 
 
 
5.4 A role for mitochondrial fission in tissue-specific 
mtDNA segregation (III) 
The morphology and distribution of the mitochondrial network have the 
potential to affect mtDNA segregation in many ways, for example through 
mediating distribution to daughter cells at cell division or affecting organelle 
turnover. This question has previously only been investigated in a single 
study in cybrid cells [286], but problems in using cybrid cell models to study 
mtDNA segregation are outlined in section 2.4. To investigate this question 
in an animal model we manipulated mitochondrial fission in the BALB/NZB 
heteroplasmic mouse model by crossing it with a mouse model expressing a 
dominant-negative mutation in Dnm1l, the master regulator of fission. This 
mutation changes a conserved cysteine residue at amino acid position 452 in 
the middle domain of Dnm1l to phenylalanine. The allele is named the 
Python (Py) mutation. The Python mutation causes the mitochondrial 
network to adopt a hyperfused network (Figure 20, [276]), and the 
Dnm1lPy/Wt mice manifest with adult-onset dilated cardiomyopathy that 
eventually leads to congestive heart failure [276].  
 69 
 
Figure 20 Visualization of mitochondrial network morphology. Representative confocal 
micrographs of mouse embryonic fibroblasts stained with an antibody against the 
mitochondrial protein Sdha derived from a Python mouse (right panel) and wild type 
control (left panel). The scale bar is 20 μm. 
5.4.1 A defect in fission does not affect transmission heteroplasmy in 
the female germ line 
In the BALB/NZB heteroplasmic mouse model the transmission of the 
heteroplasmic mtDNA variants is random [149], and the segregation of the 
variants in the female germ line follows neutral genetic drift, that is best 
modeled with a modified Kimura distribution [202]. Due to the 
mitochondrial DNA genetic bottle neck (described in sections 2.2.2 and 2.4.1) 
a range of heteroplasmy levels centering on the mothers heteroplasmy level 
is seen in the offspring [107, 202, 230]. We analyzed the heteroplasmy levels 
from ear punches of N2 offspring of F1 heteroplasmic Python mothers (see 
section 4.2.6 for details of the cross), and observed no differences in the 
range or mean heteroplasmy level of the offspring by comparison to wild type 
litter mate control mothers (Table 7). 
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Table 7 The mean and distribution of heteroplasmy in the offspring of F1 heteroplasmic 
Dnm1lPy/Wt and Dnm1Wt/Wt females. For the modified Kimura distribution analysis, 
Sidak’s adjustment for multiple testing was used to determine significance 
(α=0.0073). 
 
 
To test the data against the Kimura distribution we grouped together 
mothers with similar heteroplasmy levels as this analysis requires high n 
numbers to be effective. The heteroplasmy distribution of the offspring from 
mothers of both genotypes fit the predictions of the modified Kimura 
distribution, as indicated by the insignificant p-values (Table 7, Figure 21).  
 
 
 
 
 
 
Mothers Offspring Kimura 
Genotype %NZB Mean %NZB Range %NZB n p n 
Wt/Wt 16 17 7 - 31 34 0.910 34 
Wt/Wt 34 31 9 - 51 37 
0.012 100 Wt/Wt 34 37 12 - 62 30 
Wt/Wt 36 31 16 - 47 33 
Py/Wt 21 24 4 - 55 28 0.178 28 
Py/Wt 29 32 10 - 53 12 
0.124 54 Py/Wt 30 31 9 - 51 28 
Py/Wt 36 41 24 - 61 14 
Py/Wt 41 40 21 - 60 13 
0.052 46 Py/Wt 44 41 32 - 56 13 
Py/Wt 48 50 27 - 74 20 
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Figure 21 Example of the Kimura distribution analysis. The grey bars represent the distribution 
of the actual heteroplasmy levels observed in the offspring, and the black line the 
Kimura prediction. In these panels, data from three females of either wild type (left 
panel) or Dnm1lPy/Wt (right panel) mothers were grouped together, as shown in table 
7. The average heteroplasmy level of the mother and number of pups in the 
analysis is indicated. 
5.4.2 The effect of defective fission on somatic mtDNA segregation 
To analyze the effect of the Python mutation on somatic mtDNA segregation 
in tissues, we analyzed the heteroplasmy level across tissues in N2 generation 
produced by crossing the F1 heteroplasmic Dnm1lPy/Wt females to Balb/c 
males. 
In the BALB/NZB mouse model the segregation of the mtDNA variants 
during embryogenesis is neutral and the heteroplasmy level across tissues at 
birth is similar [238]. In most tissues post-natal mtDNA segregation is also 
neutral, the only exceptions being the well described selection phenotypes 
that occur in the liver, kidney and hematopoietic tissues [234, 235, 238]. 
Although genetic drift may have occurred in individual cells of tissues with 
neutral mtDNA segregation, the heteroplasmy level as measured from bulk 
tissue is stable with age and remains similar between tissues. 
To investigate whether neutral mtDNA segregation is affected by the 
Python mutation, we compared the heteroplasmy levels between five tissues 
where mtDNA segregation is neutral: brain, skeletal muscle, heart, small 
intestine and skin. We performed pairwise regression analysis of the tissues 
using the brain as tissue of reference. In such analysis, a line through the 
origin with a slope of 1 indicates that the values between the tissues are 
identical, and deviations from the slope of 1 signify a shift in the 
heteroplasmy levels between the tissues. We determined the best fit slope 
values with non-linear regression analysis and observed no major deviation 
from a slope of 1 for either the wild type litter mate controls or the 
Dnm1lPy/Wt animals for any of the tissues (Table 8, Figure 22). Non-linear line 
fit was selected over linear regression to allow for analysis of goodness-of-fit 
through the r2 value. When similar analysis is performed for the spleen or 
liver, where mtDNA selection occurs, the best fit slope deviates from 1. A 
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runs test of the residuals was performed to analyze whether the fitted line 
significantly deviates from the data, and was insignificant in all cases. 
 
Figure 22 Representatives of regression analysis of tissues with neutral mtDNA segregation. 
Data presented for the skeletal muscle (left panel) and skin (right panel) as 
examples. A line with a slope of 1 going through the origin is indicated with a black 
line. 
Table 8 Regression analysis of tissue heteroplasmy in N2 heteroplasmic Dnm1lPy/Wt 
animals and wild type controls. 
Brain to 
Dnm1lWt/Wt Dnm1lPy/Wt 
Slope r2 n Slope r2 n 
Heart 0.95 0.95 18 0.95 0.94 15 
Muscle 0.97 0.90 18 1.00 0.76 14 
Small 
intestine 1.07 0.90 16 1.05 0.87 15 
Skin 0.99 0.94 11 1.04 0.91 14 
Spleen 0.73 0.88 16 0.63 0.70 15 
Liver 1.29 0.87 16 1.30 0.67 16 
 
Based on these results, mitochondrial hyperfusion caused by the Python 
mutation does not affect neutral post-natal mtDNA segregation. We did not 
directly investigate mtDNA segregation during embryogenesis in this study, 
but the tissues from all three germ layers are included in this analysis: brain 
and skin from the ectoderm, muscle and heart from the mesoderm and small 
intestine from the endoderm. Therefore it is unlikely, that the Python 
mutation caused any significant changes in the random mtDNA segregation 
during intrauterine development.  
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5.4.2.1 A defect in mitochondrial fission modulates mtDNA 
segregation in the spleen 
We next analyzed whether expression of the dominant-negative Python 
mutation affects the mtDNA selection phenotypes in the spleen and liver. 
 To analyze the effect on mtDNA selection in the spleen we calculated the 
relative amount of NZB genome left in this tissue by comparing the 
heteroplasmy level in the spleen to the heteroplasmy level in neutral tissues. 
In the Dnm1lPy/Wt animals the relative amount of the NZB genome in the 
spleen was smaller than in wild type controls (Figure 23). This difference was 
statistically significant (p<0.01, two-tailed t -test). The variation within the 
groups did not differ significantly, and the degree of change in the relative 
amount of NZB in the spleen did not correlate with changes in the mtDNA 
copy number as measured by Southern blotting (Figure 23). 
 
Figure 23 MtDNA segregation and quantity in the spleen of Dnm1lPy mice. In the left panel, the 
proportion of NZB genome left in the spleen at the age of 85 days is shown (n=16 in 
both groups). Means are indicated. The right panel shows relative mtDNA quantity 
in relation to proportion of NZB left observed in the left panel.  
A dominant-negative mutation in Dnm1l could affect white blood cell 
development, and therefore the observed difference in mtDNA selection 
could reflect the presence of abnormal leukocyte numbers or aberrant ratios 
of blood cell lineages in these mice. To test this we measured basic blood 
parameters from the Dnm1lPy/Wt animals and wild type controls. No 
significant differences were observed in the amounts of major lymphoid and 
myeloid lineages in these mice (Table 9). 
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Table 9 Blood parameters from N2 heteroplasmic Dnm1lPy/Wt mice (n=5) and wild type litter 
mate controls (n=8). Data is presented as means with standard error of the mean.  
Parameter Dnm1lWt/Wt Dnm1lPy/Wt Unit 
White blood cell count  8.4 ± 1.4 9.3 ± 1.9 10E09 cells/L 
Lymphocytes 69 ± 5.1 74 ± 2.0 % 
Granulocytes 27.7 ± 5.1 20.0 ± 2.6 % 
Monocytes 1.4 ± 0.1 1.4 ± 0.4 % 
Red blood cell count 10.7 ± 0.1 10.8 ± 0.1 10E06 cells/μL 
Hemoglobin 158 ± 2.1 157 ± 3.1 g/L 
Hematocrit 56 ± 1.2 55 ± 1.0 % 
Mean corpuscular volume 53 ± 1.0 51 ± 0.7 fL 
 
To investigate if the Python mutation affected the mtDNA selection in the 
liver, we calculated the relative fitness value of the NZB genome in this 
tissue. There was no significant difference in the relative fitness of the NZB 
genome in the liver between the Dnm1lPy/Wt animals (mean = 1.080, standard 
deviation = 0.0273, n = 12) and wild type controls (mean = 1.072, standard 
deviation = 0.0212, n = 16), showing that the defect in fission did not affect 
the selective mtDNA segregation in this tissue. 
In conclusion, manipulation of mitochondrial morphology through a 
defect in fission affects the selective mtDNA segregation phenotype in the 
spleen, but does not affect mtDNA selection in the liver or the neutral 
mtDNA segregation other tissues and in the female germ line. 
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6 Discussion 
6.1 The role of Gimap3 and Gimap5 in mtDNA selection 
in leukocytes (I,II) 
When this thesis was initiated little was known about the function of Gimap3 
and Gimap5, or the function of the whole Gimap protein family. A role in 
apoptosis for Gimap3 and Gimap5 had been proposed based on three factors. 
First, loss of these proteins resulted in impaired survival of T cells in fetal 
thymocyte cultures, and overexpression of Gimap5 protected cultured cells 
from specific cell death inducers [248, 252]. Moreover, loss of Gimap5 
resulted in T cell lymphopenia in rats [253, 254, 268, 269]. Second, they both 
have been reported to localize to mitochondria, and the role of mitochondria 
in apoptosis is well established. Third, Gimap3 and Gimap5 were reported to 
co-immunoprecipitate with various members of the Bcl-2 family of apoptosis 
regulators. An interaction with the anti-apoptotic Bcl-2 and Bcl-Xl as well as 
the proapoptotic members Bax, Bak, Bad and BimEL was detected in fetal 
thymocyte cultures [248] and for Gimap5 these results were replicated for 
Bcl-2 and Bcl-Xl but not for Bad and Bax in a pre B cell line. An additional 
interaction partner Mcl-1, another antiapoptotic member of the Bcl2-family, 
was detected in the pre B cell line [264].  
The mitochondrial localization has turned out be inaccurate for both 
Gimap3 and Gimap5. Our work has placed Gimap3 in the endoplasmic 
reticulum and others have shown that Gimap5 is lysosomal protein [259]. 
While mitochondrial localization helped to form the hypothesis of apoptosis 
regulators, these subcellular localizations would still permit for a role in 
apoptosis as both ER and lysosomes are involved in the apoptotic signaling 
together with mitochondria (Reviewed in [51] and [287], respectively). 
However, our work has shown that the Cast/Ei mice are deficient for 
functional Gimap3 protein at the steady state level and yet they exhibit no 
hematological abnormality. Similarly, a genetic knock-out of Gimap3 does 
not cause any pathology in the hematopoietic lineages during normal 
development [275]. Therefore it seems unlikely that Gimap3 would be a 
major regulator of apoptosis, which is an integral part of lymphoid and 
myeloid cell development (reviewed in [288] and [289], respectively). For 
Gimap5, the situation is more complex, as loss of Gimap5 unarguably 
generates a critical cell survival and developmental defect in the 
hematopoietic compartment of mice, corroborating the results seen in 
Gimap5 deficient rats [264, 273, 274]. 
During the completion of this thesis important research on the Gimap 
proteins uncovered increasing evidence for cellular functions other than 
apoptosis, indicating that these proteins may be involved in several cellular 
processes. Based on structural homology and analysis of properties of 
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membrane-bound Gimap proteins it was proposed that Gimaps could have 
functions similar to the Septin family of scaffold proteins [260, 261]. Septins 
are involved in intracellular transport, cell migration and cell division 
(reviewed in [290]). In 2012, a small interfering RNA (siRNA) screen 
revealed that GIMAP2 and GIMAP6 knock down interferes with cargo 
delivery from the ER to the plasma membrane [291]. The following year 
GIMAP6 was implicated in macroautophagy, and the abundance of 
GABARAPL2 (the mammalian homologue of the yeast autophagy protein 
Atg8) was shown to be dependent on GIMAP6 [292]. Furthermore, the 
soluble GIMAP4 was shown to colocalize with both the tubulin and actin 
components of the cytoskeleton, and to regulate cytokine secretion in T cells 
[293]. Based on these findings, a role for Gimaps in the regulation and 
organization of intracellular trafficking seems likely. Our findings that 
Gimap3 localizes to the endoplasmic reticulum and that the abundance of 
factors involved in actin cytoskeleton regulation are dependent on Gimap5 
are consistent with such a role.  
In this thesis, we report genetic evidence that both Gimap3 and Gimap5 
modify mtDNA segregation in mouse leukocytes, and that their modifying 
effect is dependent on the abundance of these proteins. Moreover we found 
that the abundance of the ER protein Gimap3 is dependent on Gimap5 in the 
lysosomes, although the basis for this dependence is unknown. These results 
indicate that Gimap3 and Gimap5 may function in the same cellular 
pathway.  In corroboration,  recent paper suggested possible co-operation for 
Gimap3 and Gimap5 in leukocyte development [275]. In this paper another 
germ line knock-out for Gimap5 reported. The phenotype of this Gimap5 KO 
mouse is very mild by comparison to the Gimap5 KO used in this thesis or a 
Gimap5 null mouse produced by mutagenesis [273, 274], although the 
reasons for this are not clear. However, this group also reported that 
simultaneous genetic ablation of both Gimap5 and Gimap3 resulted in a 
severe phenotype similar to the two other Gimap5 null mouse strains.  
Intracellular trafficking of vesicles is of integral importance for immune 
functions such as cytokine secretion, phagocytosis, signaling via receptors of 
the innate immune system, antigen presentation and removal of intracellular 
pathogens via autophagy (reviewed in [294]). Furthermore, dynamic 
trafficking of mitochondria is also important for the function of leukocytes 
during cell migration and signaling at the immunological synapse [49, 50]. 
Leukocytes are a very specialized cell type with a distinct morphological 
feature of small cytosolic volume. These cells also constantly migrate 
throughout the body, and move to sites of infection through chemotaxis, a 
process that requires drastic and dynamic changes in cell morphology. 
Therefore, it may especially important to regulate the organization of 
subcellular organelles in this cell type. It is tempting to hypothesize that 
Gimap3 and Gimap5 would be involved in such regulation, which in turn is 
important for mtDNA segregation in leukocytes. Such a role could also 
include their reported interactions with the Bcl-2 family members. While the 
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Bcl-2 protein family members are best known as regulators of apoptosis, they 
are involved in other cellular processes as well. For example Bax and Bad 
have been shown to be involved in the regulation of mitochondrial 
morphology independent of their role in apoptosis [295, 296]. Furthermore 
Bcl-2 mediated cell death signaling overlaps with the cellular pathway for 
macroautophagy through Beclin-1 (reviewed in [297]).  
6.2 The effect of mitochondrial morphology on mtDNA 
selection and the segregating unit (III) 
Selection processes that affect mtDNA segregation could occurred on several 
different levels: the mtDNA itself, the organelle or the cell. As the molecular 
mechanisms that mediate mtDNA selection remain elusive, the level of 
selection is at present unknown. However, some inferences can be made 
based on our findings with the Python mouse where mitochondrial 
morphology is hyperfused due to a defect in Dnm1l. If a selection process was 
operating on the level of the mtDNA molecules or the cell, alteration in 
morphology of the organelle would be unlikely to affect such a process. In 
contrast, a mechanism operating on the organelle would likely be sensitive to 
changes in the morphology of the mitochondrial network. In our 
experiments, mitochondrial hyperfusion did not affect mtDNA selection in 
the liver or kidney, suggesting that the selection mechanism present in these 
tissue types is not operating on the level of the organelle. However, the 
altered mitochondrial morphology in the spleen of Python mice led to 
increased selection against the NZB mtDNA, indicative of a potential 
selection mechanism acting on the organelle level. These results are 
consistent with previous data based on differences of the the selection 
dynamics that proposes selection on the mtDNA itself in the liver and 
organelle in the hematopoietic tissues [234, 235]. 
A closely related unresolved question in the field of mtDNA genetics is the 
nature of the segregating unit. The segregating unit could be the mtDNA 
molecule, the nucleoid, a group of spatially linked nucleoids or the organelle. 
This matter is further complicated by the fact that it is not known whether 
mtDNA nucleoids are heteroplasmic or not. Knowledge of the organization of 
the nucleoid at the cytological and molecular level is very important for our 
understanding of the segregating unit, but at present remains beyond the 
technical detection capacity of even super resolution microscopy. Future 
technical advances will hopefully help increase the resolution so that this 
question can be directly investigated. 
Temporal changes in the frequency heteroplasmic mtDNA variants in 
tissues are determined either by genetic drift of selection. Both of these 
mechanisms are affected by the population size of the segregating unit: the 
smaller the population size the bigger the effect of drift, which would be 
observed as increased variation in the heteroplasmy levels. Similarly, the 
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effect of selection is faster the smaller the population of segregating units. If 
the segregating unit is the organelle, then hyperfusion would decrease the 
population size of segregating units. In such instance, an increase in 
variation caused by random drift or in the rate mtDNA selection should be 
seen. In contrast if the segregating unit is the mtDNA or nucleoids, the 
population size of segregating units should not be sensitive to changes in 
mitochondrial morphology.  
In our experiments with the Python mouse, we observed no deviation 
from the mtDNA segregation patterns normally seen in the BALB/NZB 
heteroplasmic mice in any other tissue except the spleen. This result was 
irrespective of the germ layer origin or mitotic status of the tissue. These 
findings suggest that in most tissues the population size segregating units is 
not sensitive to changes in the morphology of the organelle, providing 
indirect evidence for the hypothesis that the segregating unit is either the 
mtDNA itself or the nucleoid. In contrast, the increased mtDNA selection in 
the spleen suggests that mitochondrial hyperfusion decreased population size 
of segregating units in the spleen. Therefore it is possible that in the spleen 
the segregating unit is the organelle rather than mtDNA or nucleoids. 
The defect in fission did not have any effect in the segregation of the 
heteroplasmic mtDNA variants through the female germ line. We observed 
neither increase in variance of heteroplasmy levels in the offspring, nor a 
deviation from the random genetic drift model, showing that no selective 
mechanisms were turned on. These results indicate that the segregating unit 
in the female germ line is more likely to be mtDNA/nucleoids that individual 
organelles. Such a model is consistent with both of the mechanisms proposed 
to underlie the mitochondrial DNA bottleneck: a physical reduction in 
mtDNA copy number (and thus in the number of nucleoids) [108] or 
selective replication of a subset mtDNA molecules [107].  
6.3 New insight into the selective mtDNA segregation in 
mouse hematopoietic tissues (I-III) 
In this thesis we report three genetic modifiers of mtDNA selection in the 
hematopoietic tissues. Our data shows that proteins in other organelles can 
modulate mtDNA selection without any known direct link to mitochondria, 
demonstrating a complex picture for the regulation of selective mtDNA 
segregation in the hematopoietic tissues. While the molecular mechanism 
underlying mtDNA selection remains unknown, potential cellular pathways 
involved in mtDNA selection can be discussed based on our genetic findings 
and other advances in the field. 
The connection of mitochondria with the ER is important for many 
cellular functions, but one of special interest in relation to mtDNA 
segregation is the recently described involvement of ER in mitochondrial 
dynamics via fission, potentially via modifying the actin cytoskeleton [62, 66, 
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69]. In yeast, a link between the ER mediated and Dnm1 (yeast homolog for 
Dnm1l) dependent mitochondrial fission and the distribution of mtDNA 
nucleoids, and their segregation at yeast cell division has been established. 
This link is mediated by the ERMES complex, which is a physical interaction 
between the ER and mitochondria.  The deletion of ERMES core subunits 
leads to disruption of nucleoid structure and loss of mtDNA [58, 59, 298, 
299]. ERMES colocalizes with both replicating nucleoids and the ER 
mediated mitochondrial fission sites [63, 298]. Moreover, a recent study 
demonstrated that nucleoids are present at the majority of the ER mediated 
fission sites, and that they dynamically move and segregate to the emerging 
tips prior to the fission event, although this segregation was not observed at 
all fission sites [63]. The integral connecting factor of mitochondrial division 
and mtDNA segregation in yeast is the ERMES complex for which there is no 
mammalian counterpart identified thus far, but an analogous system could 
still be discovered.  
Our research has established that Gimap3 localizes to the ER, while 
others have shown that Gimap5 is a lysosomal protein. These proteins 
modify mtDNA segregation in the leukocytes, and may have a role in 
orchestrating organization of subcellular compartments as discussed in 
section 6.1. Our data indicates that factors involved in actin cytoskeleton 
biology are dependent on the abundance of Gimap5 in mice, and others have 
shown an association for the Gimap proteins with the actin cytoskeleton 
[293], a cellular component involved in the ER and Dnm1l mediated 
mitochondrial fission [62, 66, 69]. Furthermore, our work uncovered a direct 
genetic effect on mtDNA selection for Dnm1l. Based on these findings, a 
coupling of the ER and dnm1l mediated fission and the segregation of 
mtDNA nucleoids like in yeast would seem plausible, although the direct link 
to mtDNA nucleoids is at present missing. Mfn2, the only protein so far 
implicated in tethering mitochondria to the ER in mammalian cells, is not 
required for the ER mediated fission contact sites implying the existence of 
additional tethering factors. Gimap3 could be involved in mediating the 
interactions of ER with other organelles, including mitochondria. While we 
have no evidence that Gimap3 would function as a direct tether at ER-
mitochondrial contact sites, the ability of the membrane-bound Gimaps to 
form stable scaffolds that could function as a platform for other interacting 
factors [261, 300] is consistent with such a role. What the mechanism for 
selectivity in such model is remains to be investigated in future research.  
6.3.1 Possible mechanisms for mtDNA selection 
6.3.1.1 Selection in the hematopoietic stem cells 
Selection against cells with a high heteroplasmy level in the hematopoietic 
stem cells is a possible mechanism to explain mtDNA selection that is 
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specific for hematopoietic tissues. Mathematical modeling  suggested such a 
mechanism to explain the decrease the A3243G mutation in patients [199] 
and could underlie the selection against the NZB genome in mice, as the 
selection against these mtDNA variants occurs in a similar manner. 
Moreover, the selection against the NZB mtDNA variant is common to all 
investigated leukocyte lineages [235], consistent with a selection mechanism 
occurring either in the hematopoietic stem cell population or independently 
in all cell lineages of hematopoietic origin.  
Hematopoietic stem cells, when in quiescent state, contain few 
mitochondria and rely mainly on glycolysis for energy production while 
maintaining minimal basal metabolic activity [301, 302]. A metabolic shift to 
oxidative phosphorylation from glycolysis is associated with loss of 
quiescence and activation to lineage commitment [303]. Furthermore in 
mice mtDNA mutations have been shown cause loss of stemness and 
promote proliferation in the hematopoietic stem cell cells prior to any 
detectable defects in the respiratory chain function (reviewed in [219]). 
Therefore it is conceivable that subtle metabolic changes caused by the 
differences between the BALB and NZB mtDNA could be the underlying 
signal that leads to selection against te NZB genome in an especially sensitive 
cell type, such as the hematopoietic stem cells, even though there is no 
detectable difference in the respiratory chain function [234, 239]. 
Gimap5 is important for the normal development and maintenance of the 
hematopoietic stem cells and lack of this protein leads to a severe 
hematopoietic stem cell defect characterized by loss stem cell quiescence 
[264, 273]. The potential role for Gimap3 is the maintenance of 
hematopoietic stem cells is less clear as loss of this protein in mice does not 
cause any defects in the hematopoietic lineages, although it may play a more 
subtle role in co-operation with Gimap5 [275]. Therefore our findings that 
Gimap3 and Gimap5 are genetic modifiers of mtDNA selection in 
hematopoietic tissues are consistent with a selection mechanism occurring in 
the hematopoietic stem cells. However, our experiments do not 
experimentally address this question and further research is required to 
pinpoint whether the selection occurs in the hematopoietic stem cells. One 
potential way to clarify this issue in future research could be to isolate the 
stem cells by flow cytometric cell sorting, and directly analyze the 
heteroplasmy level in these cells in relation to the peripheral immune tissues 
at the same time point. 
6.3.1.2 Selection by innate immunity 
Mitochondria have bacterial origins and some of their components can 
therefore have the molecular appearance of intracellular pathogens: 
formylated peptides originating from mitochondrial translation and 
mitochondrial DNA have been shown to activate an innate immune reaction 
when mitochondrial contents are aberrantly released following an injury 
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[304]. Furthermore, peptides derived from the mitochondrial ND1 prime the 
adaptive immune system against the intracellular bacterium Listeria 
monocytogenes [241], and although adaptive immune responses have been 
ruled out as a mechanism for mtDNA selection [235], it is possible that 
peptides derived from ND1 are recognized by innate immune mechanisms. 
ND1 harbors one of the nucleotide differences between the BALB and NZB 
mtDNA genomes, and could serve as a signal to differentiate between these 
mtDNA variants. Interestingly recent experimental work demonstrated a role 
for Parkin, a protein implicated in marking mitochondria for degradation via 
macroautophagy in cell culture model systems, in host defence against the 
intracellular pathogens Mycobacterium tuberculosis and L. monocytogenes 
in transgenic mice [305]. Mice deficient for Parkin were shown to be 
significantly more susceptible for these pathogens. In cultured human and 
mouse macrophages Parkin was shown to colocalize with a subset of these 
pathogens, and this colocalization was prerequisite for subsequent 
colocalization with markers of autophagy. Polymorphisms in PARKIN also 
associate with susceptibility to intracellular bacterial infections in various 
human populations [306-308]. Perhaps in the mouse hematopoietic 
compartment, mitochondria harboring a high percentage of NZB are 
incorrectly perceived as an intracellular pathogen and targeted for 
destruction via an autophagic pathway.  
In principle, some of our findings are compatible with a mechanism for 
mtDNA selection that depends on mitochondrial turnover, potentially via 
macroautophagy. Our results with dominant-negative Dnm1l indicate that 
the segregating unit in the spleen is likely to be the organelle, consistent with 
a mechanism based on organelle turnover. The effect of Gimap3 could be 
facilitated through ER mediated fission, which potentially links the 
segregation of nucleoids to mitochondria targeted for degradation. Gimap5 
could mediate the final delivery of the autophagosomes to lysosome. In 
contrast our data that inhibition of fission accelerates the selection against 
the NZB genome does not support a mechanism based on autophagy, as 
fission is required to produce mitochondria that are small enough to be 
engulfed by autophagosomes.  
Although the involvement of autophagy in mtDNA selection is at present 
speculative, the innate immune system is a promising candidate for 
mediating a potential mechanism. The NK cells of the innate system have 
been shown to be able to recognize and reject cells with mtDNA variants that 
differ from the recipient upon transplantation [244]. Therefore it is possible 
to envision an immune reaction against the NZB genome in the BALB/NZB 
mouse model as the basis for mtDNA selection in these mice. It is however 
unclear why such a selection mechanism would be tissue-specific to the 
hematopoietic compartment, a shared feature between the BALB/NZB model 
and patients harboring the A3242G mutation. It is unfortunate that we were 
unable to test the involvement of NK cells in our study set up: while the 
Gimap5 KO animals lack any detectable NK cells, they cannot serve as a 
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model for NK cell depletion due the complex deficiencies of other immune 
cell types that accompany the loss of NK cells. The function of the immune 
system is to discriminate self from foreign, and in these mice the NZB 
mtDNA variant is foreign, as these mice are on a Balb/c nuclear background. 
Future research could clarify this issue by using mouse models with a specific 
defect in innate immunity.  
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7 Conclusions and future prospects 
In this thesis, we report the first genes known to be involved in tissue-specific 
mtDNA segregation in mammals. In 2010 we showed for the first time a 
modulatory effect for a specific gene, Gimap3, on tissue-specific mtDNA 
segregation in mammals. The specific function of Gimap3 in cells was 
unknown but it did not appear to be involved in in oxidative 
phosphorylation, a process conventionally proposed as potential mechanisms 
for mtDNA selection. Therefore the finding of Gimap3 enabled a whole new 
direction of research in the search for mechanisms of mtDNA segregation.  
Our follow-up research on Gimap3 revealed a picture of selective mtDNA 
segregation that is far more complex than originally envisioned. We showed 
that the Gimap3 protein consistently localizes to the endoplasmic reticulum 
instead of the previously reported mitochondrial localization. Moreover, we 
showed that Gimap5, a paralog of Gimap3 that encodes a lysosomal protein, 
is also a genetic modifier of the tissue-specific mtDNA selection phenotype in 
the spleen, potentially through some coordinated function with Gimap3. 
However, these proteins have no apparent direct link to mitochondria. In 
recent years, a potential role for Gimaps as orchestrators of intracellular 
trafficking has emerged. Moreover, it has become more apparent that 
organelles within the cell do not operate as isolated agents, although 
traditionally research has focused on the function of a specific organelle type. 
Functionally relevant interactions are now known between many organelles. 
Our findings that Gimap3 and Gimap5, proteins in separate cellular 
subcompartments can affect the segregation of mitochondrial DNA, build on 
these advances and suggest that future research should strive to encompass 
the cooperative nature of different organelles. 
Experimental evidence from the single cell eukaryotic model S. cerevisiae 
has linked ER mediated mitochondrial fission to mtDNA segregation. We 
tested the role of mitochondrial fission in mtDNA segregation in mice by 
introducing a dominant-negative mutation to the fission protein Dnm1l and 
showed that while there is a specific effect on the mtDNA selection 
phenotype in the spleen, a defect in fission is inconsequential to the mtDNA 
segregation phenotype in most tissues. Considered together with our findings 
with Gimap3 and Gimap5, it appears likely that subcellular distribution of 
mitochondria and their interactions with other organelles are relevant for the 
mtDNA selection in hematopoietic tissues. However, the mechanism for the 
selections remains unknown and further research is needed to elucidate the 
mechanistic role of these three genetic factors reported in this thesis.  
Studying the genetic and mechanistic basis for mtDNA segregation in 
mice remains highly relevant for understanding the behavior pathogenic 
mtDNA mutations in patients, as these can generally only be observed at 
static time point and cannot be studied experimentally. Due to the potential 
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mutation specific differences in the segregation behavior, it would be optimal 
generate heteroplasmic models with patient specific mtDNA mutations. 
Genetic modification of mammalian mtDNA has been unfeasible, but current 
advances in genome editing tools in the germ line may pave the way for 
studying tissue-specific segregation of patient mtDNA mutations, if they can 
be modified to work inside the mitochondria. Conceivably the generation of 
heteroplasmic models in lower vertebrates, such as zebrafish, could also be 
useful as they are more amenable for high through-put methodology than 
mice. Patient derived induced pluripotent stem cells represent another 
potential research model, although it remains to be shown whether cell based 
models even when differentiated to specialized cell types could model the 
tissue-specific segregation observed in complex animals.  
Taken together, the results described in this thesis have advanced our 
understanding of the regulation of tissue-specific mtDNA segregation. Our 
results point towards organellar interactions as being central in the 
underlying mechanism, and suggest that future research in this field should 
be directed towards ER mitochondrial interactions and organelle distribution 
to gain mechanistic insight to the process of tissue-specific mtDNA 
segregation.   
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